Details of Drug

Drug General Information (ID: D0007)
Drug Name	Abiraterone
Drug Type	Small molecule
Drug Synonymous	Abiraterone (AR inhibitor) Click to Show/Hide
Disease Class	2C82: Prostate cancer
Therapeutic Class	Antineoplastics
Structure
Structure	3D Structure		2D Structure
Formula	C24H31NO
InChI	1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1
InChIKey	GZOSMCIZMLWJML-VJLLXTKPSA-N
Canonical SMILES	CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O
External Link
	Pubchem ID	132971
	CAS Number	154229-19-3
	CHEBI ID	68642
	TTD ID	D02STN

Drug-Drug Interaction Network
Sunburst Graph		Legend Information AM002 Affected cellular transport AM004 Affected intra/extra-hepatic metabolism AM006 Pharmacodynamic additive effects AM007 Pharmacodynamic antagonistic effects BM010 Transporter inhibition BM017 CYP450 enzyme inhibition BM022 CYP450 enzyme induction BM055 Increased risk of hepatotoxicity BM076 Increased risk of prolong QT interval BM081 Increased risk of ventricular arrhythmias BM107 Attenuated pharmacological effects (Unspecific) BM109 Increased risk of other adverse reactions (Unspecific)
Relation Graph

Full list of drugs interacting with Abiraterone
Affected cellular transport
	Transporter inhibition					Drug Num: 10
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0551		Edoxaban	C24H30ClN7O4S	10280735	Major		Inter Info	[8], [14], [15], [16]
D0739		Grazoprevir	C38H50N6O9S	44603531	Major		Inter Info	[8], [21], [22]
D0182		Binimetinib	C17H15BrF2N4O3	10288191	Moderate		Inter Info	[11], [8], [206]
D0963		Lusutrombopag	C29H32Cl2N2O5S	49843517	Moderate		Inter Info	[41]
D1396		Revefenacin	C35H43N5O4	11753673	Moderate		Inter Info	[277], [21], [278]
D1407		Rimegepant	C28H28F2N6O3	51049968	Moderate		Inter Info	[279]
D1424		Romidepsin	C24H36N4O6S2	5352062	Moderate		Inter Info	[281]
D0429		Daunorubicin	C27H29NO10	30323	Moderate		Inter Info	[323], [324], [325], [326]
D0430		Daunorubicin (liposomal)	C27H29NO10	30323	Moderate		Inter Info	[323], [325], [326]
D0788		Idarubicin	C26H27NO9	42890	Moderate		Inter Info	[323], [324], [325], [326]
Affected intra/extra-hepatic metabolism
	CYP450 enzyme inhibition					Drug Num: 147
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0095		Apalutamide	C21H15F4N5O2S	24872560	Major		Inter Info	[2]
D0161		Benzhydrocodone	C25H25NO4	49836084	Major		Inter Info	[4], [5], [6]
D0202		Brexpiprazole	C25H27N3O2S	11978813	Major		Inter Info	[7]
D0559		Eliglustat	C23H36N2O4	23652731	Major		Inter Info	[17], [18]
D1169		Oliceridine	C22H30N2O2S	66553195	Major		Inter Info	[30], [18]
D1211		Ozanimod	C23H24N4O3	52938427	Major		Inter Info	[11], [32]
D1660		Tucatinib	C26H24N8O2	51039094	Major		Inter Info	[45]
D1688		Venetoclax	C45H50ClN7O7S	49846579	Major		Inter Info	[11], [8], [47]
D0772		Hydrocodone	C18H21NO3	5284569	Major		Inter Info	[4], [5]
D0947		Loperamide	C29H33ClN2O2	3955	Major		Inter Info	[112], [113], [114], [115], [116], [117]
D1203		Oxycodone	C18H21NO4	5284603	Major		Inter Info	[11], [8], [132]
D1292		Pimozide	C28H29F2N3O	16362	Major		Inter Info	[10], [11], [8], [133], [134], [18]
D1533		Tamoxifen	C26H29NO	2733526	Major		Inter Info	[145], [146], [147], [148], [149], [150], [151], [152], [153], [154], [155], [156], [157], [158], [159], [160], [161], [162], [163], [164], [165], [166], [167], [168], [169], [170], [18], [171], [172], [173], [174], [175], [176], [177], [178]
D0002		Abametapir (topical)	C12H12N2	15664	Moderate		Inter Info	[181]
D0008		Acalabrutinib	C26H23N7O2	71226662	Moderate		Inter Info	[182], [183]
D0038		Aliskiren	C30H53N3O6	5493444	Moderate		Inter Info	[10], [8], [184], [185]
D0096		Apixaban	C25H25N5O4	10182969	Moderate		Inter Info	[8], [186], [183]
D0129		Avapritinib	C26H27FN10	118023034	Moderate		Inter Info	[8], [205]
D0199		Brentuximab vedotin	NA	NA	Moderate		Inter Info	[210], [13], [211]
D0204		Brigatinib	C29H39ClN7O2P	68165256	Moderate		Inter Info	[11], [8], [212]
D0262		Cariprazine	C21H32Cl2N4O	11154555	Moderate		Inter Info	[214]
D0406		Dabrafenib	C23H20F3N5O2S2	44462760	Moderate		Inter Info	[10], [8], [2]
D0427		Dasabuvir	C26H27N3O5S	56640146	Moderate		Inter Info	[216], [217], [2]
D0543		Duvelisib	C22H17ClN6O	50905713	Moderate		Inter Info	[218]
D0555		Elagolix	C32H30F5N3O5	11250647	Moderate		Inter Info	[220]
D0562		Eluxadoline	C32H35N5O5	11250029	Moderate		Inter Info	[221]
D0638		Fedratinib	C27H36N6O3S	16722836	Moderate		Inter Info	[222], [223], [224]
D0699		Fostamatinib	C23H26FN6O9P	11671467	Moderate		Inter Info	[225]
D0866		Istradefylline	C20H24N4O4	5311037	Moderate		Inter Info	[227]
D0869		Ivacaftor	C24H28N2O3	16220172	Moderate		Inter Info	[27], [28]
D0896		Larotrectinib	C21H22F2N6O2	46188928	Moderate		Inter Info	[11], [8], [228]
D0905		Lesinurad	C17H14BrN3O2S	53465279	Moderate		Inter Info	[229]
D0946		Lonafarnib	C27H31Br2ClN4O2	148195	Moderate		Inter Info	[233]
D0953		Lorlatinib	C21H19FN6O2	71731823	Moderate		Inter Info	[234]
D0959		Lumateperone	C24H28FN3O	21302490	Moderate		Inter Info	[235]
D0961		Lurasidone	C28H36N4O2S	213046	Moderate		Inter Info	[11], [8], [236], [183]
D0962		Lurbinectedin	C41H44N4O10S	57327016	Moderate		Inter Info	[237]
D1139		Nintedanib	C31H33N5O4	135423438	Moderate		Inter Info	[238]
D1306		Polatuzumab vedotin	NA	NA	Moderate		Inter Info	[272]
D1324		Pralsetinib	C27H32FN9O2	129073603	Moderate		Inter Info	[273]
D1409		Ripretinib	C24H21BrFN5O2	71584930	Moderate		Inter Info	[11], [280]
D1457		Selexipag	C26H32N4O4S	9913767	Moderate		Inter Info	[282]
D1496		Sonidegib	C26H26F3N3O3	24775005	Moderate		Inter Info	[285]
D1505		Stiripentol	C14H18O3	5311454	Moderate		Inter Info	[8], [133], [286]
D1663		Ubrogepant	C29H26F3N5O3	68748835	Moderate		Inter Info	[288]
D1666		Upadacitinib	C17H19F3N6O	58557659	Moderate		Inter Info	[289]
D1686		Velpatasvir	C49H54N8O8	67683363	Moderate		Inter Info	[10], [8], [2]
D1718		Zanubrutinib	C27H29N5O3	135565884	Moderate		Inter Info	[290]
D0074		Amphetamine	C9H13N	3007	Moderate		Inter Info	[2]
D0105		Aripiprazole	C23H27Cl2N3O2	60795	Moderate		Inter Info	[11], [8], [297], [298], [299], [300], [301], [302]
D0119		Atomoxetine	C17H21NO	54841	Moderate		Inter Info	[304], [183], [305]
D0267		Carvedilol	C24H26N2O4	2585	Moderate		Inter Info	[2]
D0303		Cerivastatin	C26H34FNO5	446156	Moderate		Inter Info	[10], [8], [2]
D0308		Cevimeline	C10H17NOS	83898	Moderate		Inter Info	[307]
D0323		Chlorpheniramine	C16H19ClN2	2725	Moderate		Inter Info	[2]
D0324		Chlorpromazine	C17H19ClN2S	2726	Moderate		Inter Info	[2]
D0361		Clomipramine	C19H23ClN2	2801	Moderate		Inter Info	[2]
D0376		Cobimetinib	C21H21F3IN3O2	16222096	Moderate		Inter Info	[309]
D0379		Codeine	C18H21NO3	5284371	Moderate		Inter Info	[310], [311], [312], [313], [314], [315], [18], [316], [317], [318], [319], [320], [321]
D0424		Darifenacin	C28H30N2O2	444031	Moderate		Inter Info	[322], [183]
D0446		Desipramine	C18H22N2	2995	Moderate		Inter Info	[2]
D0457		Dexfenfluramine	C12H16F3N	66265	Moderate		Inter Info	[2]
D0466		Dextromethorphan	C18H25NO	5360696	Moderate		Inter Info	[11], [8], [327], [33], [183], [2]
D0467		Dextropropoxyphene	C22H29NO2	10100	Moderate		Inter Info	[328], [2], [329]
D0476		Diclofenac	C14H11Cl2NO2	3033	Moderate		Inter Info	[11], [8], [330]
D0494		Dihydroergotamine	C33H37N5O5	10531	Moderate		Inter Info	[331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353], [354], [355]
D0502		Diphenhydramine	C17H21NO	3100	Moderate		Inter Info	[2]
D0525		Doxepin	C19H21NO	667477	Moderate		Inter Info	[2]
D0539		Duloxetine	C18H19NOS	60835	Moderate		Inter Info	[356], [357]
D0592		Ergometrine	C19H23N3O2	443884	Moderate		Inter Info	[338], [340], [351]
D0593		Ergotamine	C33H35N5O5	8223	Moderate		Inter Info	[331], [332], [333], [334], [335], [336], [337], [338], [339], [340], [341], [342], [343], [344], [345], [346], [347], [348], [349], [350], [351], [352], [353], [354], [355]
D0629		Everolimus	C53H83NO14	6442177	Moderate		Inter Info	[360], [183]
D0641		Fenfluramine	C12H16F3N	3337	Moderate		Inter Info	[2]
D0664		Flecainide	C17H20F6N2O3	3356	Moderate		Inter Info	[2]
D0676		Fluoxetine	C17H18F3NO	3386	Moderate		Inter Info	[2]
D0678		Fluphenazine	C22H26F3N3OS	3372	Moderate		Inter Info	[2]
D0686		Fluvastatin	C24H26FNO4	446155	Moderate		Inter Info	[11], [8], [362], [363]
D0687		Fluvoxamine	C15H21F3N2O2	5324346	Moderate		Inter Info	[2]
D0745		Guanfacine	C9H9Cl2N3O	3519	Moderate		Inter Info	[8], [364]
D0795		Imipramine	C19H24N2	3696	Moderate		Inter Info	[2]
D0845		Irinotecan	C33H38N4O6	60838	Moderate		Inter Info	[10], [11], [8], [365], [366], [367], [368]
D0846		Irinotecan (liposomal)	C33H38N4O6	60838	Moderate		Inter Info	[11], [8], [365]
D0863		Isotretinoin	C20H28O2	5282379	Moderate		Inter Info	[10], [8], [2]
D0979		Maprotiline	C20H23N	4011	Moderate		Inter Info	[2]
D1012		Metamfetamine	C10H15N	10836	Moderate		Inter Info	[328], [2], [329]
D1019		Methdilazine	C18H20N2S	14677	Moderate		Inter Info	[2]
D1026		Methotrimeprazine	C19H24N2OS	72287	Moderate		Inter Info	[2]
D1037		Methylergometrine	C20H25N3O2	8226	Moderate		Inter Info	[338], [340], [351]
D1043		Methysergide	C21H27N3O2	9681	Moderate		Inter Info	[338], [340], [351]
D1046		Metoclopramide	C14H22ClN3O2	4168	Moderate		Inter Info	[2]
D1049		Metoprolol	C15H25NO3	4171	Moderate		Inter Info	[2]
D1054		Mexiletine	C11H17NO	4178	Moderate		Inter Info	[2]
D1061		Midodrine	C12H18N2O4	4195	Moderate		Inter Info	[2]
D1087		Montelukast	C35H36ClNO3S	5281040	Moderate		Inter Info	[370], [371]
D1114		Nebivolol	C22H25F2NO4	71301	Moderate		Inter Info	[2]
D1143		Nitisinone	C14H10F3NO5	115355	Moderate		Inter Info	[10], [11], [8]
D1158		Nortriptyline	C19H21N	4543	Moderate		Inter Info	[2]
D1194		Oxamniquine	C14H21N3O3	4612	Moderate		Inter Info	[2]
D1212		Paclitaxel	C47H51NO14	36314	Moderate		Inter Info	[376], [377], [11], [378], [379], [380], [381], [382]
D1213		Paclitaxel (protein-bound)	C47H51NO14	36314	Moderate		Inter Info	[376], [377], [11]
D1229		Paroxetine	C19H20FNO3	43815	Moderate		Inter Info	[2]
D1293		Pindolol	C14H20N2O2	4828	Moderate		Inter Info	[2]
D1294		Pioglitazone	C19H20N2O3S	4829	Moderate		Inter Info	[385], [386], [387], [388], [389], [390], [391], [392], [393]
D1299		Pirfenidone	C12H11NO	40632	Moderate		Inter Info	[8], [394], [18]
D1346		Prochlorperazine	C20H24ClN3S	4917	Moderate		Inter Info	[2]
D1351		Promazine	C17H20N2S	4926	Moderate		Inter Info	[2]
D1352		Promethazine	C17H20N2S	4927	Moderate		Inter Info	[2]
D1353		Propafenone	C21H27NO3	4932	Moderate		Inter Info	[2]
D1355		Propiomazine	C20H24N2OS	4940	Moderate		Inter Info	[2]
D1357		Propranolol	C16H21NO2	4946	Moderate		Inter Info	[2]
D1361		Protriptyline	C19H21N	4976	Moderate		Inter Info	[2]
D1392		Repaglinide	C27H36N2O4	65981	Moderate		Inter Info	[405], [406], [407], [408], [393]
D1413		Risperidone	C23H27FN4O2	5073	Moderate		Inter Info	[2]
D1429		Rosiglitazone	C18H19N3O3S	77999	Moderate		Inter Info	[409], [410], [411], [412], [413], [391], [393]
D1534		Tamsulosin	C20H28N2O5S	129211	Moderate		Inter Info	[414], [415], [416], [18]
D1572		Thiethylperazine	C22H29N3S2	5440	Moderate		Inter Info	[2]
D1585		Timolol	C13H24N4O3S	33624	Moderate		Inter Info	[2]
D1586		Timolol (ophthalmic)	C13H24N4O3S	33624	Moderate		Inter Info	[418], [419], [420]
D1611		Torasemide	C16H20N4O3S	41781	Moderate		Inter Info	[423], [424], [425]
D1616		Tramadol	C16H25NO2	33741	Moderate		Inter Info	[11], [427], [8], [187], [188], [189], [190], [191], [428], [192], [193], [2], [429]
D1624		Trazodone	C19H22ClN5O	5533	Moderate		Inter Info	[2]
D1625		Treprostinil	C23H34O5	6918140	Moderate		Inter Info	[430]
D1626		Tretinoin	C20H28O2	444795	Moderate		Inter Info	[10], [8], [2]
D1637		Trifluoperazine	C21H24F3N3S	5566	Moderate		Inter Info	[2]
D1638		Triflupromazine	C18H19F3N2S	5568	Moderate		Inter Info	[2]
D1647		Trimipramine	C20H26N2	5584	Moderate		Inter Info	[2]
D1689		Venlafaxine	C17H27NO2	5656	Moderate		Inter Info	[2]
D0192		Boceprevir	C27H45N5O5	10324367	Minor		Inter Info	[2]
D0375		Cobicistat	C40H53N7O5S2	25151504	Minor		Inter Info	[2]
D0425		Darolutamide	C19H19ClN6O2	67171867	Minor		Inter Info	[431]
D0518		Doravirine	C17H11ClF3N5O3	58460047	Minor		Inter Info	[432]
D1104		Naloxegol	C34H53NO11	56959087	Minor		Inter Info	[433]
D1653		Troleandomycin	C41H67NO15	202225	Minor		Inter Info	[2]
D0080		Amprenavir	C25H35N3O6S	65016	Minor		Inter Info	[2]
D0116		Atazanavir	C38H52N6O7	148192	Minor		Inter Info	[2]
D0208		Brivaracetam	C11H20N2O2	9837243	Minor		Inter Info	[8], [434]
D0386		Conivaptan	C32H26N4O2	151171	Minor		Inter Info	[2]
D0439		Delavirdine	C22H28N6O3S	5625	Minor		Inter Info	[2]
D0516		Donepezil	C24H29NO3	3152	Minor		Inter Info	[435], [18], [436], [437]
D0692		Fosamprenavir	C25H36N3O9PS	131536	Minor		Inter Info	[2]
D0799		Indinavir	C36H47N5O4	5362440	Minor		Inter Info	[2]
D0867		Itraconazole	C35H38Cl2N8O4	55283	Minor		Inter Info	[2]
D1117		Nefazodone	C25H32ClN5O2	4449	Minor		Inter Info	[2]
D1119		Nelfinavir	C32H45N3O4S	64143	Minor		Inter Info	[2]
D1415		Ritonavir	C37H48N6O5S2	392622	Minor		Inter Info	[2]
D1541		Telaprevir	C36H53N7O6	3010818	Minor		Inter Info	[2]
D1607		Tolterodine	C22H31NO	443879	Minor		Inter Info	[445], [446], [18]
	CYP450 enzyme induction					Drug Num: 18
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0578		Enzalutamide	C21H16F4N4O2S	15951529	Major		Inter Info	[2]
D0958		Lumacaftor	C24H18F2N2O5	16678941	Major		Inter Info	[27], [28], [2]
D0255		Carbamazepine	C15H12N2O	2554	Major		Inter Info	[2]
D1078		Mitotane	C14H10Cl4	4211	Major		Inter Info	[2]
D1265		Phenobarbital	C12H12N2O3	4763	Major		Inter Info	[2]
D1283		Phenytoin	C15H12N2O2	1775	Major		Inter Info	[2]
D1340		Primidone	C12H14N2O2	4909	Major		Inter Info	[2]
D1399		Rifabutin	C46H62N4O11	135398743	Major		Inter Info	[2]
D1400		Rifampicin	C43H58N4O12	135398735	Major		Inter Info	[27], [28], [2]
D1401		Rifapentine	C47H64N4O12	135403821	Major		Inter Info	[2]
D1502		St. John's Wort	NA	NA	Major		Inter Info	[2]
D0300		Cenobamate	C10H10ClN5O2	11962412	Moderate		Inter Info	[215]
D0545		Echinacea	NA	NA	Moderate		Inter Info	[11], [219]
D1493		Somapacitan	C54H95N13O20S2	129894493	Moderate		Inter Info	[11], [8], [283]
D1495		Somatrem	C43H72N14O14	5487805	Moderate		Inter Info	[11], [8], [284], [283]
D1546		Telotristat ethyl	C27H26ClF3N6O3	25181577	Moderate		Inter Info	[8], [287]
D1128		Nevirapine	C15H14N4O	4463	Moderate		Inter Info	[11], [8], [373], [374]
D1494		Somatotropin	NA	NA	Moderate		Inter Info	[11], [8], [283]
Pharmacodynamic additive effects
	Increased risk of hepatotoxicity					Drug Num: 20
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1258		Pexidartinib	C20H15ClF3N5	25151352	Major		Inter Info	[35]
D1556		Teriflunomide	C12H9F3N2O2	54684141	Major		Inter Info	[10], [43], [44]
D0900		Leflunomide	C12H9F3N2O2	3899	Major		Inter Info	[10], [43], [44]
D1073		Mipomersen	C230H324N67O122P19S19	118984467	Major		Inter Info	[130]
D0113		Asparaginase Erwinia chrysanthemi	NA	NA	Moderate		Inter Info	[194], [195], [196], [11], [8], [197], [198], [199], [200], [201], [202], [203], [204]
D0232		Calaspargase pegol	NA	NA	Moderate		Inter Info	[194], [195], [196], [11], [8], [197], [198], [199], [200], [201], [202], [203], [204]
D0248		Cannabidiol	C21H30O2	644019	Moderate		Inter Info	[8], [213]
D0789		Idelalisib	C22H18FN7O	11625818	Moderate		Inter Info	[226]
D1239		Peginterferon beta-1a	NA	NA	Moderate		Inter Info	[266], [267], [268], [269]
D1389		Remdesivir	C27H35N6O8P	121304016	Moderate		Inter Info	[11], [8], [274], [275], [276]
D0114		Asparaginase Escherichia coli	NA	NA	Moderate		Inter Info	[194], [195], [196], [11], [8], [197], [198], [303], [200], [201], [202], [203], [204]
D0357		Clofarabine	C10H11ClFN5O3	119182	Moderate		Inter Info	[308]
D0554		Efavirenz	C14H9ClF3NO2	64139	Moderate		Inter Info	[358], [359]
D0826		Interferon beta-1a	NA	NA	Moderate		Inter Info	[266], [267], [268], [269]
D0827		Interferon beta-1b	NA	NA	Moderate		Inter Info	[266], [267], [268], [269]
D1025		Methotrexate	C20H22N8O5	126941	Moderate		Inter Info	[8], [369]
D1106		Naltrexone	C20H23NO4	5360515	Moderate		Inter Info	[372]
D1234		Pegaspargase	C14H19NO	436058	Moderate		Inter Info	[194], [195], [196], [11], [8], [197], [198], [199], [200], [201], [202], [203], [204]
D1589		Tioguanine	C5H5N5S	2723601	Moderate		Inter Info	[421], [422]
D1615		Trabectedin	C39H43N3O11S	108150	Moderate		Inter Info	[8], [426]
	Increased risk of prolong QT interval					Drug Num: 129
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0067		Amisulpride	C17H27N3O4S	2159	Major		Inter Info	[1]
D0149		Bedaquiline	C32H31BrN2O2	5388906	Major		Inter Info	[3]
D0230		Cabozantinib	C28H24FN3O5	25102847	Major		Inter Info	[8], [9]
D0302		Ceritinib	C28H36ClN5O3S	57379345	Major		Inter Info	[10], [11], [8], [12]
D0393		Crizotinib	C21H22Cl2FN5O	11626560	Major		Inter Info	[13]
D0872		Ivosidenib	C28H22ClF3N6O3	71657455	Major		Inter Info	[25]
D0899		Lefamulin	C28H45NO5S	25185057	Major		Inter Info	[26]
D0965		Macimorelin	C26H30N6O3	9804938	Major		Inter Info	[29]
D1190		Osimertinib	C28H33N7O2	71496458	Major		Inter Info	[31]
D1221		Panobinostat	C21H23N3O2	6918837	Major		Inter Info	[33]
D1230		Pasireotide	C58H66N10O9	9941444	Major		Inter Info	[10], [11], [8], [34]
D1398		Ribociclib	C23H30N8O	44631912	Major		Inter Info	[10], [11], [8], [37], [38], [39], [40], [41]
D1459		Selpercatinib	C29H31N7O3	134436906	Major		Inter Info	[8], [42]
D1687		Vemurafenib	C23H18ClF2N3O3S	42611257	Major		Inter Info	[10], [11], [8], [46]
D0066		Amiodarone	C25H29I2NO3	2157	Major		Inter Info	[10], [11], [8], [48], [49], [50], [51], [52], [53], [54], [55], [56], [41]
D0084		Anagrelide	C10H7Cl2N3O	135409400	Major		Inter Info	[10], [11], [8], [57]
D0342		Cisapride	C23H29ClFN3O4	6917698	Major		Inter Info	[10], [11], [8], [60], [61], [62]
D0345		Citalopram	C20H21FN2O	2771	Major		Inter Info	[10], [11], [8], [63], [64], [41], [20]
D0508		Disopyramide	C21H29N3O	3114	Major		Inter Info	[10], [11], [8], [48], [49], [50], [51], [52], [53], [54], [55], [56], [41]
D0513		Dofetilide	C19H27N3O5S2	71329	Major		Inter Info	[10], [11], [8], [65]
D0514		Dolasetron	C19H20N2O3	3033818	Major		Inter Info	[10], [11], [8], [66]
D0534		Dronedarone	C31H44N2O5S	208898	Major		Inter Info	[10], [11], [8], [67]
D0535		Droperidol	C22H22FN3O2	3168	Major		Inter Info	[10], [11], [8], [37], [68], [41]
D0599		Escitalopram	C20H21FN2O	146570	Major		Inter Info	[10], [69], [11], [8], [70], [71], [41]
D0712		Gatifloxacin	C19H22FN3O4	5379	Major		Inter Info	[72], [73], [74], [10], [11], [8], [75], [76], [77], [78], [38], [79], [80], [81], [82], [83], [84], [85], [86], [87], [88], [89], [90], [91], [92], [93]
D0740		Grepafloxacin	C19H22FN3O3	72474	Major		Inter Info	[73], [10], [11], [8], [94], [95], [96]
D0749		Halofantrine	C26H30Cl2F3NO	37393	Major		Inter Info	[97], [10], [11], [8], [98], [99], [100], [101], [102]
D0750		Haloperidol	C21H23ClFNO2	3559	Major		Inter Info	[10], [11], [8], [103], [104], [105], [106], [107], [108], [41]
D0787		Ibutilide	C20H36N2O3S	60753	Major		Inter Info	[10], [11], [8], [109]
D0791		Iloperidone	C24H27FN2O4	71360	Major		Inter Info	[10], [11], [8], [110], [41]
D0909		Levacetylmethadol	C23H31NO2	15130	Major		Inter Info	[8], [111], [41]
D1010		Mesoridazine	C21H26N2OS2	4078	Major		Inter Info	[10], [11], [8], [118], [41]
D1017		Methadone	C21H27NO	4095	Major		Inter Info	[10], [11], [8], [119], [120], [121], [122], [123], [124], [125], [126], [127], [128], [41]
D1063		Mifepristone	C29H35NO2	55245	Major		Inter Info	[10], [11], [8], [129]
D1136		Nilotinib	C28H22F3N7O	644241	Major		Inter Info	[10], [11], [8], [131]
D1343		Procainamide	C13H21N3O	4913	Major		Inter Info	[10], [11], [8], [48], [49], [50], [51], [52], [53], [54], [55], [56], [41]
D1371		Quinidine	C20H24N2O2	441074	Major		Inter Info	[10], [11], [8], [48], [49], [50], [51], [52], [53], [54], [55], [56], [41]
D1444		Saquinavir	C38H50N6O5	441243	Major		Inter Info	[135], [136], [10], [11], [8], [137], [138]
D1498		Sotalol	C12H20N2O3S	5253	Major		Inter Info	[10], [11], [8], [48], [49], [50], [51], [52], [53], [54], [55], [56], [41]
D1499		Sparfloxacin	C19H22F2N4O3	60464	Major		Inter Info	[73], [10], [11], [8], [139], [140], [77], [38], [80], [141], [81], [82], [142], [84], [85], [86], [87], [143], [91], [96], [144]
D1612		Toremifene	C26H28ClNO	3005573	Major		Inter Info	[10], [11], [8], [133]
D1681		Vandetanib	C22H24BrFN4O2	3081361	Major		Inter Info	[10], [11], [8], [179]
D1726		Ziprasidone	C21H21ClN4OS	60854	Major		Inter Info	[10], [11], [8], [37], [180], [41]
D0112		Asenapine	C17H16ClNO	3036780	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0195		Bosutinib	C26H29Cl2N5O3	5328940	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0452		Deutetrabenazine	C19H27NO3	73437646	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0569		Encorafenib	C22H27ClFN7O4S	50922675	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0577		Entrectinib	C31H34F2N6O2	25141092	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0594		Eribulin	C40H59NO11	11354606	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0720		Gilteritinib	C29H44N8O3	49803313	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0725		Glasdegib	C21H22N6O	25166913	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0806		Inotuzumab ozogamicin	NA	NA	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0903		Lenvatinib	C21H19ClN4O4	9823820	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0940		Lithium carbonate	CLi2O3	11125	Moderate		Inter Info	[8], [192], [193]
D1062		Midostaurin	C35H30N4O4	9829523	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1189		Osilodrostat	C13H10FN3	44139752	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1232		Pazopanib	C21H23N7O2S	10113978	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1404		Rilpivirine	C22H18N6	6451164	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1432		Rucaparib	C19H18FN3O	9931954	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1542		Telavancin	C80H106Cl2N11O27P	3081362	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1634		Triclabendazole	C14H9Cl3N2OS	50248	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1673		Valbenazine	C24H38N2O4	24795069	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0036		Alfuzosin	C19H27N5O4	2092	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0037		Alimemazine	C18H22N2S	5574	Moderate		Inter Info	[8], [192], [193]
D0068		Amitriptyline	C20H23N	2160	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0072		Amoxapine	C17H16ClN3O	2170	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0097		Apomorphine	C17H17NO2	6005	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0115		Astemizole	C28H31FN4O	2247	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0139		Azithromycin	C38H72N2O12	447043	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0219		Buprenorphine	C29H41NO4	644073	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0320		Chloroquine	C18H26ClN3	2719	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0336		Cilostazol	C20H27N5O2	2754	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0341		Ciprofloxacin	C17H18FN3O3	2764	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0349		Clarithromycin	C38H69NO13	84029	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0358		Clofazimine	C27H22Cl2N4	2794	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0428		Dasatinib	C22H26ClN7O2S	3062316	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0526		Doxepin (topical)	C19H21NO	667477	Moderate		Inter Info	[8], [192], [193]
D0528		Doxorubicin	C27H29NO11	31703	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0529		Doxorubicin (liposomal)	C27H29NO11	31703	Moderate		Inter Info	[8], [192], [193]
D0584		Epirubicin	C27H29NO11	41867	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0597		Erythromycin	C37H67NO13	12560	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0632		Ezogabine	C16H18FN3O2	121892	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0636		Famotidine	C8H15N7O2S3	5702160	Moderate		Inter Info	[11], [8], [361]
D0667		Fluconazole	C13H12F2N6O	3365	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0694		Foscarnet	CH3O5P	3415	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0716		Gemifloxacin	C18H20FN5O4	9571107	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0738		Granisetron	C18H24N4O	5284566	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0751		Halothane	C2HBrClF3	3562	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0779		Hydroxychloroquine	C18H26ClN3O	3652	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0781		Hydroxyzine	C21H27ClN2O2	3658	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0880		Ketoconazole	C26H28Cl2N4O4	456201	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0894		Lapatinib	C29H26ClFN4O4S	208908	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0919		Levofloxacin	C18H20FN3O4	149096	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0937		Lisdexamfetamine	C15H25N3O	11597698	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0942		Lofexidine	C11H12Cl2N2O	30668	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0943		Lomefloxacin	C17H19F2N3O3	3948	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D0948		Lopinavir	C37H48N4O5	92727	Moderate		Inter Info	[8], [192], [193]
D0992		Mefloquine	C17H16F6N2O	4046	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1075		Mirtazapine	C17H19N3	4205	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1165		Ofloxacin	C18H20FN3O4	4583	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1166		Olanzapine	C17H20N4S	135398745	Moderate		Inter Info	[11], [8], [375]
D1181		Ondansetron	C18H19N3O	4595	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1193		Oxaliplatin	C8H14N2O4Pt	9887053	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1210		Oxytocin	C43H66N12O12S2	439302	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1215		Paliperidone	C23H27FN4O3	115237	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1216		Palonosetron	C19H24N2O	6337614	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1246		Pentamidine	C19H24N4O2	4735	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1254		Perflutren	C3F8	6432	Moderate		Inter Info	[383], [384]
D1290		Pimavanserin	C25H34FN3O2	10071196	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1339		Primaquine	C15H21N3O	4908	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1342		Probucol	C31H48O2S2	4912	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1356		Propofol	C12H18O	4943	Moderate		Inter Info	[395], [396], [397], [398], [399], [400], [401], [402], [403], [404]
D1368		Quetiapine	C21H25N3O2S	5002	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1372		Quinine	C20H24N2O2	3034034	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1383		Ranolazine	C24H33N3O4	56959	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1461		Sertraline	C17H17Cl2N	68617	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1463		Sevoflurane	C4H3F7O	5206	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1491		Solifenacin	C23H26N2O2	154059	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1522		Sunitinib	C22H27FN4O2	5329102	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1526		Tacrolimus	C44H69NO12	445643	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1544		Telithromycin	C43H65N5O10	3002190	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1555		Terfenadine	C32H41NO2	5405	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1560		Tetrabenazine	C19H27NO3	6018	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1596		Tizanidine	C9H8ClN5S	5487	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1682		Vardenafil	C23H32N6O4S	135400189	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1683		Vasopressin	C46H65N15O12S2	644077	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1706		Voriconazole	C16H14F3N5O	71616	Moderate		Inter Info	[8], [187], [188], [189], [190], [191], [192], [193]
D1051		Metronidazole	C6H9N3O3	4173	Minor		Inter Info	[11], [438], [439], [440]
D1516		Sulfamethoxazole	C10H11N3O3S	5329	Minor		Inter Info	[10], [11], [8], [441], [442], [443], [444]
	Increased risk of ventricular arrhythmias					Drug Num: 32
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D0661		Fingolimod	C19H33NO2	107970	Major		Inter Info	[10], [11], [8], [19], [20]
D0868		Ivabradine	C27H36N2O5	132999	Major		Inter Info	[8], [23], [24]
D0107		Arsenic trioxide	As2O3	14888	Major		Inter Info	[58], [59]
D0184		Bisacodyl	C22H19NO4	2391	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D0269		Castor oil	C57H104O9	14030006	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D0701		Frangula purshiana bark	NA	NA	Moderate		Inter Info	[11], [8], [209]
D0731		Glycerin	C3H8O3	753	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D0887		Lactitol	C12H24O11	157355	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D0924		Levosalbutamol	C13H21NO3	123600	Moderate		Inter Info	[230], [231], [232]
D0970		Magnesium citrate	C12H10Mg3O14	6099959	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D0973		Magnesium hydroxide	H2MgO2	14791	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D1069		Mineral oil	NA	NA	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D1171		Olodaterol	C21H26N2O5	11504295	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D1287		Picosulfuric acid	C18H15NO8S2	5243	Moderate		Inter Info	[8], [270], [271]
D1308		Polyethylene glycol (3350 with electrolytes)	C2H6O2	174	Moderate		Inter Info	[8], [270], [271]
D1309		Polyethylene glycol (3350)	C2H6O2	174	Moderate		Inter Info	[11], [8], [209]
D1488		Sodium sulfate	Na2O4S	24436	Moderate		Inter Info	[8], [270], [271]
D1695		Vilanterol	C24H33Cl2NO5	10184665	Moderate		Inter Info	[230], [231], [232]
D0025		Adenosine	C10H13N5O4	60961	Moderate		Inter Info	[10], [291], [11], [8], [292], [293], [294], [60], [295], [296]
D0103		Arformoterol	C19H24N2O4	3083544	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D0691		Formoterol	C19H24N2O4	3410	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D0797		Indacaterol	C24H28N2O3	6918554	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D0854		Isoetharine	C13H21NO3	3762	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D0859		Isoprenaline	C11H17NO3	3779	Moderate		Inter Info	[230], [231], [232]
D0888		Lactulose	C12H22O11	11333	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D1266		Phenolphthalein	C20H14O4	4764	Moderate		Inter Info	[10], [11], [8], [207], [208], [209]
D1298		Pirbuterol	C12H20N2O3	4845	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D1414		Ritodrine	C17H21NO3	33572	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D1438		Salbutamol	C13H21NO3	2083	Moderate		Inter Info	[230], [231], [232]
D1440		Salmeterol	C25H37NO4	5152	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D1554		Terbutaline	C12H19NO3	5403	Moderate		Inter Info	[239], [240], [241], [242], [243], [244], [245], [246], [247], [248], [249], [250], [251], [230], [252], [253], [254], [255], [256], [257], [258], [259], [260], [231], [261], [262], [232], [263], [264], [265]
D1569		Thalidomide	C13H10N2O4	5426	Moderate		Inter Info	[11], [8], [417]
	Increased risk of other adverse reactions (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1375		Radium Ra 223 dichloride	NA	NA	Major		Inter Info	[11], [8], [36]
Pharmacodynamic antagonistic effects
	Attenuated pharmacological effects (Unspecific)					Drug Num: 1
Drug ID		Drug Name	Formula	Pubchem ID	Severity Level		Interaction Detail	REF
D1756		Capromab pendetide	C10H15N5O11P2	135509147	Moderate		Inter Info	[306]

References
1	Product Information. Barhemsys (amisulpride). Acacia Pharma, Inc, Indianapolis, IN.
2	Product Information. Zytiga (abiraterone). Centocor Inc, Malvern, PA.
3	Product Information. Sirturo (bedaquiline). Janssen Pharmaceuticals, Titusville, NJ.
4	Hutchinson MR, Menelaou A, Foster DJ, Coller JK, Somogyi AA "CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes." Br J Clin Pharmacol 57 (2004): 287-97. [PMID: 14998425]
5	Product Information. Zohydro ER (HYDROcodone). Zogenix, Inc, San Diego, CA.
6	Vizcaychipi MP, Walker S, Palazzo M "Serotonin syndrome triggered by tramadol." Br J Anaesth 99 (2007): 919. [PMID: 18006535]
7	Product Information. Rexulti (brexpiprazole). Otsuka American Pharmaceuticals Inc, Rockville, MD.
8	Cerner Multum, Inc. "UK Summary of Product Characteristics.".
9	Product Information. Cometriq (cabozantinib). Exelixis Inc, S San Francisco, CA.
10	Canadian Pharmacists Association.
11	Cerner Multum, Inc. "Australian Product Information.".
12	Product Information. Zykadia (ceritinib). Novartis Pharmaceuticals, East Hanover, NJ.
13	Product Information. Xalkori (crizotinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
14	Mendell J, Zahir H, Matsushima N, et al. "Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor." Am J Cardiovasc Drugs (2013):. [PMID: 23784266]
15	Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K "Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine." Br J Clin Pharmacol 0 (2016): epub. [PMID: 27530188]
16	Product Information. Savaysa (edoxaban). Daiichi Sankyo, Inc., Parsippany, NJ.
17	Product Information. Cerdelga (eliglustat). Genzyme Corporation, Cambridge, MA.
18	Product Information. Varubi (rolapitant). Tesaro Inc., Waltham, MA.
19	Product Information. Gilenya (fingolimod). Novartis Pharmaceuticals, East Hanover, NJ.
20	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod).".
21	Product Information. Nexlizet (bempedoic acid-ezetimibe). Esperion Therapeutics, Ann Arbor, MI.
22	Product Information. Zepatier (elbasvir-grazoprevir). Merck &amp Company Inc, Whitehouse Station, NJ.
23	Mittal SR "Slow junctional rhythm, QTc prolongation and transient torsades de-pointes following combined use of Ivabradine, Diltiazem and Ranolazine." J Assoc Physicians India 62 (2014): 426-7. [PMID: 25438492]
24	Product Information. Corlanor (ivabradine). Amgen USA, Thousand Oaks, CA.
25	Product Information. Tibsovo (ivosidenib). Agios Pharmaceuticals, Cambridge, MA.
26	Product Information. Xenleta (lefamulin). Nabriva Therapeutics US, Inc., King of Prussia, PA.
27	Product Information. Kalydeco (ivacaftor). Vertex Pharmaceuticals, Cambridge, MA.
28	Product Information. Orkambi (ivacaftor-lumacaftor). Vertex Pharmaceuticals, Cambridge, MA.
29	Product Information. Macrilen (macimorelin). Aeterna Zentaris, Charleston, SC.
30	Product Information. Olinvyk (oliceridine). Trevena Inc, Chesterbrook, PA.
31	Product Information. Tagrisso (osimertinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
32	Product Information. Zeposia (ozanimod). Celgene Corporation, Summit, NJ.
33	Product Information. Farydak (panobinostat). Novartis Pharmaceuticals, East Hanover, NJ.
34	Product Information. Signifor (pasireotide). Novartis Pharmaceuticals, East Hanover, NJ.
35	Product Information. Turalio (pexidartinib). Daiichi Sankyo, Inc., Parsippany, NJ.
36	Bayer HealthCare Pharmaceuticals, Inc "Important Drug Warning: Xofigo."
37	Glassman AH, Bigger JT Jr "Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death." Am J Psychiatry 158 (2001): 1774-82. [PMID: 11691681]
38	Iannini PB "Cardiotoxicity of macrolides, ketolides and fluoroquinolones that prolong the QTc interval." Expert Opin Drug Saf 1 (2002): 121-8. [PMID: 12904146]
39	Product Information. Kisqali (ribociclib). Novartis Pharmaceuticals, East Hanover, NJ.
40	Witchel HJ, Hancox JC, Nutt DJ "Psychotropic drugs, cardiac arrhythmia, and sudden death." J Clin Psychopharmacol 23 (2003): 58-77. [PMID: 12544377]
41	EMA. European Medicines Agency. European Union "EMA - List of medicines under additional monitoring.".
42	Product Information. Retevmo (selpercatinib). Lilly, Eli and Company, Indianapolis, IN.
43	EMEA "EMEA public statement on leflunomide (ARAVA) - severe and serious hepatic reactions.".
44	Product Information. Arava (leflunomide). Hoechst Marion-Roussel Inc, Kansas City, MO.
45	Product Information. Tukysa (tucatinib). Seattle Genetics Inc, Bothell, WA.
46	Product Information. Zelboraf (vemurafenib). Genentech, South San Francisco, CA.
47	Product Information. Venclexta (venetoclax). AbbVie US LLC, North Chicago, IL.
48	Maxa JL, Hebeler RF, Adeeko MA "Torsades de pointes following concurrent amiodarone and levofloxacin therapy." Proc (Bayl Univ Med Cent) 19 (2006): 345-6. [PMID: 17106497]
49	Product Information. Betapace (sotalol). Berlex, Richmond, CA.
50	Product Information. Cordarone (amiodarone). Wyeth-Ayerst Laboratories, Philadelphia, PA.
51	Product Information. Norpace (disopyramide). Searle, Skokie, IL.
52	Product Information. Procan SR (procainamide). Parke-Davis, Morris Plains, NJ.
53	Product Information. Quiniglute (quinidine). Berlex, Richmond, CA.
54	Product Information. Vascor (bepridil). McNeil Pharmaceutical, Raritan, NJ.
55	Trujillo TC, Nolan PE "Antiarrhythmic agents - Drug interactions of clinical significance." Drug Safety 23 (2000): 509-32. [PMID: 11144659]
56	Yamreudeewong W, DeBisschop M, Martin L, Lower D "Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs." Drug Saf 26 (2003): 421-38. [PMID: 12688833]
57	Product Information. Agrylin (anagrelide). Roberts Pharmaceutical Corporation, Eatontown, NJ.
58	Ohnishi K, Yoshida H, Shigeno K, et al. "Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia." Ann Intern Med 133 (2000): 881-5. [PMID: 11103058]
59	Product Information. Trisenox (arsenic trioxide) Cephalon Inc, West Chester, PA.
60	Michalets EL, Williams CR "Drug interactions with cisapride: clinical implications." Clin Pharmacokinet 39 (2000): 49-75. [PMID: 10926350]
61	Product Information. Propulsid (cisapride). Janssen Pharmaceutica, Titusville, NJ.
62	Trinkle R "Comment: syncopal episodes associated with cisapride." Ann Pharmacother 33 (1999): 251. [PMID: 10084425]
63	FDA. U.S. Food and Drug Administration "FDA Drug Safety Communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide).".
64	Product Information. Celexa (citalopram). Forest Pharmaceuticals, St. Louis, MO.
65	Product Information. Tikosyn (dofetilide) Pfizer US Pharmaceuticals, Atlanta, GA.
66	Product Information. Anzemet (dolasetron). Hoechst Marion-Roussel Inc, Kansas City, MO.
67	Product Information. Multaq (dronedarone). sanofi-aventis , Bridgewater, NJ.
68	Product Information. Inapsine (droperidol). Janssen Pharmaceutica, Titusville, NJ.
69	Castro VM, Clements CC, Murphy SN, et al. "QT interval and antidepressant use: a cross sectional study of electronic health records." BMJ 346 (2013): f288. [PMID: 23360890]
70	Do A, Noohi S, Elie D, et al. Health Canada Warning on Citalopram and Escitalopram--Its Effects on Prescribing in Consultation-Liaison Psychiatry.?Psychosomatics. 2016;57(1):57-63. [PMID: 26633294]
71	Product Information. Lexapro (escitalopram). Forest Pharmaceuticals, St. Louis, MO.
72	Ansari SR, Chopra N "Gatifloxacin and Prolonged QT Interval." Am J Med Sci 327 (2004): 55-6. [PMID: 14722399]
73	Ball P "Quinolone-induced QT interval prolongation: a not-so-unexpected class effect." J Antimicrob Chemother 45 (2000): 557-9. [PMID: 10797074]
74	Bertino JS Jr, Owens RC Jr, Carnes TD, Iannini PB "Gatifloxacin-associated corrected QT interval prolongation, torsades de pointes, and ventricular fibrillation in patients with known risk factors." Clin Infect Dis 34 (2002): 861-3. [PMID: 11830802]
75	Dale KM, Lertsburapa K, Kluger J, White CM "Moxifloxacin and torsade de pointes." Ann Pharmacother 41 (2007): 336-40. [PMID: 17284508]
76	Demolis JL, Kubitza D, Tenneze L, Funck-Bretano C "Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects." Clin Pharmacol Ther 68 (2000): 658-66. [PMID: 11180026]
77	Falagas ME, Rafailidis PI, Rosmarakis ES "Arrhythmias associated with fluoroquinolone therapy." Int J Antimicrob Agents 29 (2007): 374-9. [PMID: 17241772]
78	Frothingham R "Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin." Pharmacotherapy 21 (2001): 1468-72. [PMID: 11765299]
79	Iannini PB, Circiumaru I "Gatifloxacin-induced QTc prolongation and ventricular tachycardia." Pharmacotherapy 21 (2001): 361-2. [PMID: 11253862]
80	Iannini PB, Doddamani S, Byazrova E, Curciumaru I, Kramer H "Risk of torsades de pointes with non-cardiac drugs." BMJ 322 (2001): 46-7. [PMID: 11141163]
81	Kang J, Wang L, Chen XL, Triggle DJ, Rampe D "Interactions of a series of fluoroquinolone antibacterial drugs with the human cardiac K+ channel HERG." Mol Pharmacol 59 (2001): 122-6. [PMID: 11125032]
82	Katritsis D, Camm AJ "Quinolones: cardioprotective or cardiotoxic." Pacing Clin Electrophysiol 26 (2003): 2317-20. [PMID: 14675020]
83	Noel GJ, Natarajan J, Chien S, Hunt TL, Goodman DB, Abels R "Effects of three fluoroquinolones on QT interval in healthy adults after single doses." Clin Pharmacol Ther 73 (2003): 292-303. [PMID: 12709719]
84	Oliphant CM, Green GM "Quinolones: a comprehensive review." Am Fam Physician 65 (2002): 455-64. [PMID: 11858629]
85	Owens RC "QT Prolongation with Antimicrobial Agents : Understanding the Significance." Drugs 64 (2004): 1091-124. [PMID: 15139788]
86	Owens RC "Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes." Pharmacotherapy 21 (2001): 301-19. [PMID: 11253855]
87	Owens RC Jr, Ambrose PG "Torsades de pointes associated with fluoroquinolones." Pharmacotherapy 22 (2002): 663-8 discussion 668-72. [PMID: 12013370]
88	Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
89	Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
90	Siepmann M, Kirch W "Drug points - Tachycardia associated with moxifloxacin." Br Med J 322 (2001): 23. [PMID: 11141146]
91	Stahlmann R "Clinical toxicological aspects of fluoroquinolones." Toxicol Lett 127 (2002): 269-77. [PMID: 12052667]
92	Tsikouris JP, Peeters MJ, Cox CD, Meyerrose GE, Seifert CF "Effects of three fluoroquinolones on QT analysis after standard treatment courses." Ann Noninvasive Electrocardiol 11 (2006): 52-6. [PMID: 16472283]
93	White CM, Grant EM, Quintiliani R "Moxifloxacin does increase the corrected QT interval." Clin Infect Dis 33 (2001): 1441-2. [PMID: 11565091]
94	Lode H, Vogel F, Elies W "Grepafloxacin: A review of its safety profile based on clinical trials and postmarketing surveillance." Clin Ther 21 (1999): 61-74. [PMID: 10090425]
95	Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
96	Thomas M, Maconochie JG, Fletcher E "The dilemma of the prolonged QT interval in early drug studies." Br J Clin Pharmacol 41 (1996): 77-81. [PMID: 8838432]
97	Abernethy DR, Wesche DL, Barbey JT, et al. "Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation." Br J Clin Pharmacol 51 (2001): 231-7. [PMID: 11298069]
98	Giao PT, de Vries PJ "Pharmacokinetic interactions of antimalarial agents." Clin Pharmacokinet 40 (2001): 343-73. [PMID: 11432537]
99	Nosten F, ter Kuile FO, Luxemburger C, et al "Cardiac effects of antimalarial treatment with halofantrine." Lancet 341 (1993): 1054-6. [PMID: 8096959]
100	Product Information. Halfan (halofantrine). GlaxoSmithKline, Philadelphia, PA.
101	Product Information. Lariam (mefloquine). Roche Laboratories, Nutley, NJ.
102	Sudden death in a traveler following halofantrine administration--Togo, 2000. MMWR Morb Mortal Wkly Rep 50 (2001): 169-70, 179. [PMID: 11393488]
103	Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, Yonezawa Y "The association between intravenous haloperidol and prolonged QT interval." J Clin Psychopharmacol 21 (2001): 257-61. [PMID: 11386487]
104	Huyse F, van Schijndel RS "Haloperidol and cardiac arrest." Lancet 2 (1988): 568-9. [PMID: 2900948]
105	Metzger E, Friedman R "Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill." J Clin Psychopharmacol 13 (1993): 128-32. [PMID: 8463445]
106	O'Brien JM, Rockwood RP, Suh KI "Haloperidol-induced torsade de pointes." Ann Pharmacother 33 (1999): 1046-9. [PMID: 10534216]
107	Product Information. Haldol (haloperidol). McNeil Pharmaceutical, Raritan, NJ.
108	Wilt JL, Minnema AM, Johnson RF, Rosenblum AM "Torsade de pointes associated with the use of intravenous haloperidol." Ann Intern Med 119 (1993): 391-4. [PMID: 8338292]
109	Product Information. Corvert (ibutilide). Pharmacia and Upjohn, Kalamazoo, MI.
110	Product Information. Exforge HCT (amlodipine/hydrochlorothiazide/valsartan). Novartis Pharmaceuticals, East Hanover, NJ.
111	Product Information. Orlaam (levomethadyl acetate) Roxanne Laboratories Inc, Columbus, OH.
112	Eggleston W, Clark KH, Marraffa JM "Loperamide abuse associated with cardiac dysrhythmia and death." Ann Emerg Med 69 (2017): 83-6. [PMID: 27140747]
113	Kim KA, Chung J, Jung DH, Park JY "Identification of cytochrome P450 isoforms involved in the metabolism of loperamide in human liver microsomes." Eur J Clin Pharmacol 60 (2004): 575-81. [PMID: 15365656]
114	Niemi M, Tornio A, Pasanen MK, Fredrikson H, Neuvonen PJ, Backman JT "Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide." Eur J Clin Pharmacol 62 (2006): 463-72. [PMID: 16758263]
115	Product Information. Imodium (loperamide). Janssen Pharmaceutica, Titusville, NJ.
116	Tayrouz Y, Ganssmann B, Ding R, et al. "Ritonavir increases loperamide plasma concentrations without evidence for P-glycoprotein involvement." Clin Pharmacol Ther 70 (2001): 405-14. [PMID: 11719726]
117	US Food and Drug Administration "FDA warns about serious heart problems with high doses of the antidiarrheal medicine loperamide (Imodium), including from abuse and misuse.".
118	Product Information. Serentil (mesoridazine) Boehringer-Ingelheim, Ridgefield, CT.
119	De Bels D, Staroukine M, Devriendt J "Torsades de pointes due to methadone." Ann Intern Med 139 (2003): E156. [PMID: 12859181]
120	Ehret GB, Desmeules JA, Broers B "Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology." Expert Opin Drug Saf 6 (2007): 289-303. [PMID: 17480178]
121	Gil M, Sala M, Anguera I, et al. "QT prolongation and Torsades de Pointes in patients infected with human immunodeficiency virus and treated with methadone." Am J Cardiol 92 (2003): 995-7. [PMID: 14556883]
122	Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS "Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes." Pharmacotherapy 23 (2003): 802-5. [PMID: 12820821]
123	Krantz MJ, Lewkowiez L, Hays H, et al "Torsade de pointes associated with very-high-dose methadone." Ann Intern Med 137 (2002): 501-4. [PMID: 12230351]
124	Krantz MJ, Mehler PS "Synthetic opioids and QT prolongation." Arch Intern Med 163 (2003): 1615 author reply 1615. [PMID: 12860589]
125	Martell BA, Arnsten JH, Krantz MJ, Gourevitch MN "Impact of methadone treatment on cardiac repolarization and conduction in opioid users." Am J Cardiol 95 (2005): 915-8. [PMID: 15781034]
126	Mokwe EO, Ositadinma O "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966000]
127	Sala M, Anguera I, Cervantes M "Torsade de pointes due to methadone." Ann Intern Med 139 (2003): W64. [PMID: 12966001]
128	Walker PW, Klein D, Kasza L "High dose methadone and ventricular arrhythmias: a report of three cases." Pain 103 (2003): 321-4. [PMID: 12791438]
129	Product Information. Korlym (mifepristone). Corcept Therapeutics Incorporated, Menlo Park, CA.
130	Product Information. Kynamro (mipomersen). Genzyme Corporation, Cambridge, MA.
131	Product Information. Tasigna (nilotinib). Novartis Pharmaceuticals, East Hanover, NJ.
132	Product Information. OxyContin (oxycodone). Purdue Frederick Company, Norwalk, CT.
133	EMEA. European Medicines Agency "EPARs. European Union Public Assessment Reports.".
134	Product Information. Orap Tablets (pimozide). Gate Pharmaceuticals, Sellersville, PA.
135	Anson BD, Weaver JG, Ackerman MJ, et al. "Blockade of HERG channels by HIV protease inhibitors." Lancet 365 (2005): 682-686. [PMID: 15721475]
136	Biondi L "Health Canada endorsed important safety information on Invirase (saquinavir mesylate)." .
137	Product Information. Invirase (saquinavir). Roche Laboratories, Nutley, NJ.
138	FDA. U.S. Food and Drug Administration "FDA drug safety communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms.".
139	Demolis JL, Charransol A, Funck-Brentano C, Jaillon P "Effects of a single oral dose of sparfloxacin on ventricular repolarization in healthy volunteers." Br J Clin Pharmacol 41 (1996): 499-503. [PMID: 8799513]
140	Dupont H, Timsit JF, Souweine B, Gachot B, Wolff M, Regnier B "Torsades de pointe probably related to sparfloxacin." Eur J Clin Microbiol Infect Dis 15 (1996): 350-1. [PMID: 8781892]
141	Jaillon P, Morganroth J, Brumpt I, Talbot G "Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group." J Antimicrob Chemother 37(suppl a) (1996): 161-7. [PMID: 8737135]
142	Lipsky BA, Dorr MB, Magner DJ, Talbot GH "Safety profile of sparfloxacin, a new fluoroquinolone antibiotic." Clin Ther 21 (1999): 148-59. [PMID: 10090432]
143	Product Information. Zagam (sparfloxacin). Rhone-Poulenc Rorer, Collegeville, PA.
144	Zix JA, GeerdesFenge HF, Rau M, Vockler J, Borner K, Koeppe P, Lode H "Pharmacokinetics of sparfloxacin and interaction with cisapride and sucralfate." Antimicrob Agents Chemother 41 (1997): 1668-72. [PMID: 9257738]
145	Amchin J, Ereshefsky L, Zarycranski W, Taylor K, Albano D, Klockowski PM "Effect of venlafaxine versus fluoxetine on metabolism of dextromethorphan, a CYP2D6 probe." J Clin Pharmacol 41 (2001): 443-51. [PMID: 11304901]
146	Aubert RE, Stanek EJ, Yao J, et al "Increased risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors".
147	Bonanni B, Macis D, Maisonneuve P, et al. "Polymorphism in the CYP2D6 tamoxifen-metabolizing gene influences clinical effect but not hot flashes: data from the Italian Tamoxifen Trial." J Clin Oncol 24 (2006): 3708-9. [PMID: 16877740]
148	Borges S, Desta Z, Li L, et al. "Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment." Clin Pharmacol Ther 80 (2006): 61-74. [PMID: 16815318]
149	Borgna JL, Rochefort H "Hydroxylated metabolites of tamoxifen are formed in vivo and bound to estrogen receptor in target tissues." J Biol Chem 256 (1981): 859-68. [PMID: 7451477]
150	Brauch H, Murdter TE, Eichelbaum M, Schwab M "Pharmacogenomics of tamoxifen therapy." Clin Chem 55 (2009): 1770-82. [PMID: 19574470]
151	Coller JK, Krebsfaenger N, Klein K, et al. "The influence of CYP2B6, CYP2C9 and CYP2D6 genotypes on the formation of the potent antioestrogen Z-4-hydroxy-tamoxifen in human liver." Br J Clin Pharmacol 54 (2002): 157-167. [PMID: 12207635]
152	Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE "The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes." Br J Clin Pharmacol 34 (1992): 262-5. [PMID: 1389951]
153	Dehal SS, Kupfer D "CYP2D6 catalyzes tamoxifen 4-hydroxylation in human liver." Cancer Res 57 (1997): 3402-6. [PMID: 9270005]
154	Desta Z, Flockhart DA "Germline pharmacogenetics of tamoxifen response: have we learned enough?" J Clin Oncol 25 (2007): 5147-9. [PMID: 18024859]
155	Desta Z, Ward BA, Soukhova NV, Flockhart DA "Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6." J Pharmacol Exp Ther (2004):. [PMID: 15159443]
156	Dezentje VO, Guchelaar HJ, Nortier JW, van de Velde CJ, Gelderblom H "Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer." Clin Cancer Res 15 (2009): 15-21. [PMID: 19118028]
157	Gaston C, Kolesar J "Clinical Significance of CYP2D6 Polymorphisms and Tamoxifen in Women with Breast Cancer." Clin Adv Hematol Oncol 6 (2008): 825-33. [PMID: 19194367]
158	Goetz MP, Kamal A, Ames MM "Tamoxifen Pharmacogenomics: The Role of CYP2D6 as a Predictor of Drug Response." Clin Pharmacol Ther (2007):. [PMID: 17882159]
159	Goetz MP, Loprinzi CL "A hot flash on tamoxifen metabolism." J Natl Cancer Inst 95 (2003): 1734-5. [PMID: 14652227]
160	Goetz MP, Rae JM, Suman VJ, et al. "Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes." J Clin Oncol 23 (2005): 9312-8. [PMID: 16361630]
161	Henry NL, Stearns V, Flockhart DA, Hayes DF, Riba M "Drug interactions and pharmacogenomics in the treatment of breast cancer and depression." Am J Psychiatry 165 (2008): 1251-5. [PMID: 18829880]
162	Jin Y, Desta Z, Stearns V, et al. "CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment." J Natl Cancer Inst 97 (2005): 30-9. [PMID: 15632378]
163	Johnson MD, Zuo H, Lee KH, et al. "Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen." Breast Cancer Res Treat 85 (2004): 151-9. [PMID: 15111773]
164	Jordan VC "Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance." Breast Cancer Res Treat 2 (1982): 123-38. [PMID: 6184101]
165	Jordan VC, Collins MM, Rowsby L, Prestwich G "A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity." J Endocrinol 75 (1977): 305-16. [PMID: 591813]
166	Lash TL, Pedersen L, Cronin-Fenton D, et al "Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram." Br J Cancer 99 (2008): 616-21. [PMID: 20385012]
167	Lehmann D, Nelsen J, Ramanath V, Newman N, Duggan D, Smith A "Lack of attenuation in the antitumor effect of tamoxifen by chronic CYP isoform inhibition." J Clin Pharmacol 44 (2004): 861-5. [PMID: 15286089]
168	Lim HS, Ju Lee H, Seok Lee K, Sook Lee E, Jang IJ, Ro J "Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer." J Clin Oncol 25 (2007): 3837-45. [PMID: 17761971]
169	McCaffrey P "Genetics and drug interactions affect tamoxifen metabolism." Lancet Oncol 6 (2005): 72. [PMID: 15704296]
170	Ponzone R, Biglia N, Sismondi P "Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 96 (2004): 883-4 author reply 884-5. [PMID: 15173274]
171	Rochat B "Role of cytochrome p450 activity in the fate of anticancer agents and in drug resistance : focus on tamoxifen, Paclitaxel and imatinib metabolism." Clin Pharmacokinet 44 (2005): 349-66. [PMID: 15828850]
172	Schroth W, Antoniadou L, Fritz P, et al. "Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes." J Clin Oncol 25 (2007): 5187-93. [PMID: 18024866]
173	Stearns V, Johnson MD, Rae JM, et al. "Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 95 (2003): 1758-64. [PMID: 14652237]
174	Wegman P, Elingarami S, Carstensen J, Stal O, Nordenskjold B, Wingren S "Genetic variants of CYP3A5, CYP2D6, SULT1A1, UGT2B15 and tamoxifen response in postmenopausal patients with breast cancer." Breast Cancer Res 9 (2007): R7. [PMID: 17244352]
175	Wegman P, Vainikka L, Stal O, et al "Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients." Breast Cancer Res 7 (2005): R284-90. [PMID: 15987423]
176	Young D "Genetics examined in tamoxifen's effectiveness: recurrence warning urged for labeling." Am J Health Syst Pharm 63 (2006): 2286, 2296. [PMID: 17105997]
177	Crewe HK, Notley LM, Wunsch RM, Lennard MS, Gillam EM "Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4'-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen." Drug Metab Dispos 30 (2002): 869-74. [PMID: 12124303]
178	Ratliff B, Dietze EC, Bean GR, Moore C, Wanko S, Seewaldt VL "Re: Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine." J Natl Cancer Inst 96 (2004): 883 author reply 884-5. [PMID: 15173275]
179	Product Information. Vandetanib (vandetanib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
180	Product Information. Geodon (ziprasidone). Pfizer US Pharmaceuticals, New York, NY.
181	Product Information. Xeglyze (abametapir topical). Dr. Reddy's Laboratories Inc, Upper Saddle River, NJ.
182	Product Information. Calquence (acalabrutinib). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
183	Product Information. Qelbree (viloxazine). Supernus Pharmaceuticals Inc, Rockville, MD.
184	Product Information. Tekturna (aliskiren). Novartis Pharmaceuticals, East Hanover, NJ.
185	Tapaninen T, Backman JT, Kurkinen K, Neuvonen P, Niemi M "Itraconazole, a P-glycoprotein and CYP3A4 inhibitor, markedly raises the plasma concentrations and enhances the renin-inhibiting effect of aliskiren." J Clin Pharmacol 51 (2011): 359-67. [PMID: 20400651]
186	Product Information. Eliquis (apixaban). Bristol-Myers Squibb Canada Inc, Montreal, IN.
187	Product Information. Eligard (leuprolide). Sanofi Winthrop Pharmaceuticals, New York, NY.
188	Product Information. Firmagon (degarelix). Ferring Pharmaceuticals Inc, Tarrytown, NY.
189	Product Information. Lupron (leuprolide). TAP Pharmaceuticals Inc, Deerfield, IL.
190	Product Information. Plenaxis (abarelix). Praecis Pharmaceuticals Inc, Waltham, MA.
191	Product Information. Trelstar (triptorelin) Pharmacia and Upjohn, Kalamazoo, MI.
192	Product Information. Vantas (histrelin). Endo Pharmaceuticals (formally Indevus Pharmaceuticals Inc), Lexington, MA.
193	Product Information. Zoladex (goserelin). Zeneca Pharmaceuticals, Wilmington, DE.
194	Al-Nawakil C, Willems L, Mauprivez C, et.al "Successful treatment of l-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactors." Leuk Lymphoma 55 (2014): 1670-4. [PMID: 24090500]
195	Bodmer M, Sulz M, Stadlmann S, Droll A, Terracciano L, Krahenbuhl S "Fatal liver failure in an adult patient with acute lymphoblastic leukemia following treatment with L-asparaginase." Digestion 74 (2006): epub. [PMID: 16988508]
196	Cerner Multum, Inc "ANVISA Bulario Eletrnico.".
197	Christ TN, Stock W, Knoebel RW "Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen." J Oncol Pharm Pract 24 (2018): 299-308. [PMID: 28355969]
198	Jenkins R, Perlin E "Severe hepatotoxicity from Escherichia coli L-asparaginase." J Natl Med Assoc 79 (1987): 775-9. [PMID: 3305969]
199	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine" Proc (Bayl Univ Med Cent) 29 (2016): 46-7. [PMID: 26722167]
200	Product Information. Asparlas (calaspargase pegol). Servier, Boston, MA.
201	Product Information. Elspar (asparaginase). Merck & Co, Inc, West Point, PA.
202	Product Information. Erwinaze (asparaginase Erwinia chrysanthemi). EUSA Pharma, Newtown, PA.
203	Product Information. Oncaspar (pegaspargase). Rhone-Poulenc Rorer, Collegeville, PA.
204	Burke PW, Aldoss I, Lunning MA, et.al "High-grade PEGylated asparaginase-related hepatotoxicity occurrence in a pediatric-inspired adult acute lymphoblastic leukemia regimen does not necessarily predict recurrent hepatotoxicity in subsequent cycles." Blood 122 (2013): 2671. [PMID: 29407583]
205	Product Information. Ayvakit (avapritinib). Blueprint Medicines Corporation, Cambridge, MA.
206	Product Information. Mektovi (binimetinib). Array BioPharma Inc., Boulder, CO.
207	Chin RL "Laxative-induced hypokalemia." Ann Emerg Med 32 (1998): 517-8. [PMID: 9774942]
208	Muller-Lissner SA "Adverse effects of laxatives: fact and fiction." Pharmacology 47 (1993): 138-45. [PMID: 8234421]
209	Schaefer DC, Cheskin LJ "Constipation in the elderly." Am Fam Physician 58 (1998): 907-14. [PMID: 9767726]
210	Product Information. VFEND (voriconazole). Pfizer U.S. Pharmaceuticals, New York, NY.
211	Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
212	Product Information. Alunbrig (brigatinib). Ariad Pharmaceuticals Inc, Cambridge, MA.
213	Product Information. Epidiolex (cannabidiol). Greenwich Biosciences Inc, Carlsbad, CA.
214	Product Information. Vraylar (cariprazine). Actavis Pharma, Inc., Parsippany, NJ.
215	Product Information. Xcopri (cenobamate). SK Life Science, Inc., Paramus, NJ.
216	Product Information. Norvir (ritonavir). Abbott Pharmaceutical, Abbott Park, IL.
217	Product Information. Viekira Pak (dasabuvir/ombitasvir/paritaprevir/ritonavir). AbbVie US LLC, North Chicago, IL.
218	Product Information. Copiktra (duvelisib). Verastem, Inc., Needham, MA.
219	Gorski JC, Huang SM, Pinto A, et al. "The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo." Clin Pharmacol Ther 75 (2004): 89-100. [PMID: 14749695]
220	Product Information. Orilissa (elagolix). AbbVie US LLC, North Chicago, IL.
221	Product Information. Viberzi (eluxadoline). Actavis Pharma, Inc., Parsippany, NJ.
222	Dimartini A "Isoniazid, tricyclics and the ''cheese reaction''." Int Clin Psychopharmacol 10 (1995): 197-8. [PMID: 8675973]
223	Product Information. INH (isoniazid). Ciba Pharmaceuticals, Summit, NJ.
224	Product Information. Inrebic (fedratinib). Celgene Corporation, Summit, NJ.
225	Product Information. Tavalisse (fostamatinib). Rigel Pharmaceuticals, South San Francisco, CA.
226	Product Information. Zydelig (idelalisib). Gilead Sciences, Foster City, CA.
227	Product Information. Nourianz (istradefylline). Kyowa Kirin, Inc, Bedminster, NJ.
228	Product Information. Vitrakvi (larotrectinib). Bayer Pharmaceutical Inc, West Haven, CT.
229	Product Information. Zurampic (lesinurad). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
230	Product Information. Arcapta Neohaler (indacaterol). Novartis Pharmaceuticals, East Hanover, NJ.
231	Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA "Metabolic and cardiovascular effects of carbuterol and metaproterenol." J Allergy Clin Immunol 60 (1977): 174-9. [PMID: 19514]
232	Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71. [PMID: 3545273]
233	Product Information. Zokinvy (lonafarnib). Eiger BioPharmaceuticals, Palo Alto, CA.
234	Product Information. Lorbrena (lorlatinib). Pfizer U.S. Pharmaceuticals Group, New York, NY.
235	Product Information. Caplyta (lumateperone). Intra-Cellular Therapies, Inc., New York, NY.
236	Product Information. Latuda (lurasidone). Sunovion Pharmaceuticals Inc, Marlborough, MA.
237	Product Information. Zepzelca (lurbinectedin). Jazz Pharmaceuticals, Palo Alto, CA.
238	Product Information. Ofev (nintedanib). Boehringer Ingelheim, Ridgefield, CT.
239	Bengtsson B, Fagerstrom PO "Extrapulmonary effects of terbutaline during prolonged administration." Clin Pharmacol Ther 31 (1982): 726-32. [PMID: 7042176]
240	Braden GL, vonOeyen PT, Germain MJ, Watson DJ, Haag BL "Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences." Kidney Int 51 (1997): 1867-75. [PMID: 9186877]
241	Clifton GD, Hunt BA, Patel RC, Burki NK "Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses." Am Rev Respir Dis 141 (1990): 575-9. [PMID: 2178522]
242	Dickens GR, Mccoy RA, West R, Stapczynski JS, Clifton GD "Effect of nebulized albuterol on serum potassium and cardiac rhythm in patients with asthma or chronic obstructive pulmonary disease." Pharmacotherapy 14 (1994): 729-33. [PMID: 7885977]
243	Ferguson GT, Funck-Brentano C, Fischer T, Darken P, Reisner C "Cardiovascular Safety of Salmeterol in COPD." Chest 123 (2003): 1817-24. [PMID: 12796155]
244	Gelmont DM, Balmes JR, Yee A "Hypokalemia induced by inhaled bronchodilators." Chest 94 (1988): 763-6. [PMID: 3168573]
245	Gross TL, Sokol RJ "Severe hypokalemia and acidosis: a potential complication of beta- adrenergic treatment." Am J Obstet Gynecol 138 (1980): 1225-6. [PMID: 7446635]
246	Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9. [PMID: 708661]
247	Hurlbert BJ, Edelman JD, David K "Serum potassium levels during and after terbutaline." Anesth Analg 60 (1981): 723-5. [PMID: 7197475]
248	Hypokalaemia due to salbutamol overdosage. Br Med J (Clin Res Ed) 283 (1981): 500-1. [PMID: 6114774]
249	Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20. [PMID: 3956296]
250	Lowe MD, Rowland E, Brown MJ, Grace AA "Beta(2) adrenergic receptors mediate important electrophysiological effects in human ventricular myocardium." Heart 86 (2001): 45-51. [PMID: 11410561]
251	Milic M, Bao X, Rizos D, Liu F, Ziegler MG "Literature review and pilot studies of the effect of qt correction formulas on reported beta(2)-agonist-induced QTc prolongation." Clin Ther 28 (2006): 582-90. [PMID: 16750469]
252	Product Information. Breo Ellipta (fluticasone-vilanterol). GlaxoSmithKline, Research Triangle Park, NC.
253	Product Information. Brovana (arformoterol). Sepracor Inc, Marlborough, MA.
254	Product Information. Foradil (formoterol) Novartis Pharmaceuticals, East Hanover, NJ.
255	Product Information. Maxair (pirbuterol). 3M Pharmaceuticals, St. Paul, MN.
256	Product Information. Proventil (albuterol). Schering Laboratories, Kenilworth, NJ.
257	Product Information. Severent (salmeterol). Glaxo Wellcome, Research Triangle Park, NC.
258	Product Information. Striverdi Respimat (olodaterol). Boehringer Ingelheim, Ridgefield, CT.
259	Product Information. Xopenex (levalbuterol). Sepracor, Marlborough, MA.
260	Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7. [PMID: 9583400]
261	Sun ZH, Swan H, Vitasalo M, Toivonen L "Effects of epinephrine and phenylephrine on QT interval dispersion in congenital long QT syndrome." J Am Coll Cardiol 31 (1998): 1400-5. [PMID: 9581741]
262	Tveskov C, Djurhuus MS, Klitgaard NAH, Egstrup K "Potassium and magnesium distribution, ECG changes, and ventricular ectopic beats during beta(2)-adrenergic stimulation with terbutaline in healthy subjects." Chest 106 (1994): 1654-9. [PMID: 7988180]
263	Windom H, Grainger J, Burgess C, Crane J, Pearce N, Beasley R "A comparison of the haemodynamic and hypokalaemic effects of inhaled pirbuterol and salbutamol." N Z Med J 103 (1990): 259-61. [PMID: 1972557]
264	Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9. [PMID: 1978872]
265	Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9. [PMID: 921062]
266	Product Information. Avonex (interferon beta-1a). Biogen, Cambridge, MA.
267	Product Information. Betaseron (interferon beta-1b). Berlex, Richmond, CA.
268	Product Information. Plegridy (peginterferon beta-1a). Biogen Idec Inc, Cambridge, MA.
269	Product Information. Rebif (interferon beta-1a). Serono Laboratories Inc, Norwell, MA.
270	Product Information. Suclear (polyethylene glycol 3350 with electrolytes). Braintree Laboratories, Braintree, MA.
271	Product Information. Suprep Bowel Prep Kit (magnesium/potassium/sodium sulfates). Braintree Laboratories, Braintree, MA.
272	Product Information. Polivy (polatuzumab vedotin). Genentech, South San Francisco, CA.
273	Product Information. Gavreto (pralsetinib). Blueprint Medicines Corporation, Cambridge, MA.
274	European Medicines Agency "Summary on compassionate use. Remdesivir Gilead.".
275	Gilead Sciences, Inc "About Remdesivir.".
276	US Food and Drug Administration "Fact sheet for health care providers emergency use authorization (EUA) of remdesivir (GS-5734TM)".
277	Product Information. Nexletol (bempedoic acid). Esperion Therapeutics, Ann Arbor, MI.
278	Product Information. Yupelri (revefenacin). Mylan Specialty, Morgantown, WV.
279	Product Information. Nurtec ODT (rimegepant). Biohaven Pharmaceuticals, New Haven, CT.
280	Product Information. Qinlock (ripretinib). Deciphera Pharmaceuticals, Waltham, MA.
281	Product Information. Istodax (romidepsin). Gloucester Pharmaceuticals, Cambridge, MA.
282	Product Information. Uptravi (selexipag). Actelion Pharmaceuticals US Inc, South San Francisco, CA.
283	Product Information. Zorbtive (somatropin). Serono Laboratories Inc, Rockland, MA.
284	Product Information. Humatrope (somatropin). Lilly, Eli and Company, Indianapolis, IN.
285	Product Information. Odomzo (sonidegib). Novartis Pharmaceuticals, East Hanover, NJ.
286	Product Information. Diacomit (stiripentol). Biocodex Inc, Creswell, OR.
287	Product Information. Xermelo (telotristat ethyl). Lexicon Pharmaceuticals, Inc., The Woodlands, TX.
288	Product Information. Ubrelvy (ubrogepant). Allergan Inc, Irvine, CA.
289	Product Information. Rinvoq (upadacitinib). AbbVie US LLC, North Chicago, IL.
290	Product Information. Brukinsa (zanubrutinib). BeiGene USA, Inc, San Mateo, CA.
291	Celiker A, Tokel K, Cil E, Ozkutlu S, Ozme S "Adenosine induced torsades de pointes in a child with congenital long QT syndrome." Pacing Clin Electrophysiol 17 (1994): 1814-7. [PMID: 7838793]
292	Teodorovich N, Margolin E, Kogan Y, Paz O, Swissa M. Torsades de pointes after adenosine administration. J Electrocardiol. 2016;49(2):171-173. [PMID: 26850499]
293	Harrington GR, Froelich EG "Adenosine-induced torsades de pointes." Chest 103 (1993): 1299-1301. [PMID: 8131497]
294	Mallet ML "Proarrhythmic effects of adenosine: a review of the literature." Emerg Med J 21 (2004): 408-10. [PMID: 15208219]
295	Tachakra SS, Robinson S "Adenosine and cardiac arrhythmias." BMJ 305 (1992): 422. [PMID: 1392935]
296	Wesley RC Jr, Turnquest P "Torsades de pointe after intravenous adenosine in the presence of prolonged QT syndrome." Am Heart J 123 (1992): 794-6. [PMID: 1539535]
297	Goodnick PJ, Jerry J, Parra F "Psychotropic drugs and the ECG: focus on the QTc interval." Expert Opin Pharmacother 3 (2002): 479-98. [PMID: 11996627]
298	Kane JM, Carson WH, Saha AR, et al. "Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder." J Clin Psychiatry 63 (2002): 763-71. [PMID: 12363115]
299	Keck PE Jr, Marcus R, Tourkodimitris S, et al. "A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania." Am J Psychiatry 160 (2003): 1651-8. [PMID: 12944341]
300	Nelson S, Leung JG "Torsades de Pointes After Administration of Low-Dose Aripiprazole (February)." Ann Pharmacother (2013):. [PMID: 23362038]
301	Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG "Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study." J Clin Psychiatry 64 (2003): 1048-56. [PMID: 14628980]
302	Product Information. Abilify (aripiprazole). Bristol-Myers Squibb, Princeton, NJ.
303	Lu G, Karur V, Herrington JD, Walker MG "Successful treatment of pegaspargase-induced acute hepatotoxicity with vitamin B complex and L-carnitine. [PMID: 26722167]
304	Belle DJ, Ernest CS, Sauer JM, Smith BP, Thomasson HR, Witcher JW "Effect of potent CYP2D6 inhibition by paroxetine on atomoxetine pharmacokinetics." J Clin Pharmacol 42 (2002): 1219-27. [PMID: 12412820]
305	Product Information. Strattera (atomoxetine). Lilly, Eli and Company, Indianapolis, IN.
306	Product Information. ProstaScint (capromab pendetide). Aytu BioScience, Inc, Englewood, CO.
307	Product Information. Evoxac (cevimeline) Daiichi Pharmaceuticals, Fort lee, NJ.
308	Product Information. Clolar (clofarabine). sanofi-aventis, Bridgewater, NJ.
309	Product Information. Cotellic (cobimetinib). Genentech, South San Francisco, CA.
310	Caraco Y, Sheller J, Wood AJJ "Impact of ethnic origin and quinidine coadministration on codeine's disposition and pharmacodynamic effects." J Pharmacol Exp Ther 290 (1999): 413-22. [PMID: 10381807]
311	Caraco Y, Sheller J, Wood JJ "Pharmacogenetic determination of the effects of codeine and prediction of drug interactions." J Pharmacol Exp Ther 278 (1996): 1165-74. [PMID: 8819499]
312	Desmeules J, Dayer P, Gascon MP, Magistris M "Impact of genetic and environmental factors on codeine analgesia." Clin Pharmacol Ther 45 (1989): 122. [PMID: 1782973]
313	Desmeules J, Gascon MP, Dayer P, Magistris M "Impact of environmental and genetic factors on codeine analgesia." Eur J Clin Pharmacol 41 (1991): 23-6. [PMID: 1782973]
314	Hersh EV, Moore PA "Drug interactions in dentistry: the importance of knowing your CYPs." J Am Dent Assoc 135 (2004): 298-311. [PMID: 15058617]
315	Poulsen L, Brosen K, Srendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH "Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects." Eur J Clin Pharmacol 51 (1996): 289-95. [PMID: 9010701]
316	Sindrup SH, Arendt-Nielsen L, Brosen K, et al "The effect of quinidine on the analgesic effect of codeine." Eur J Clin Pharmacol 42 (1992): 587-92. [PMID: 1623898]
317	Sindrup SH, Brosen K, Bjerring P, et al. "Codeine increases pain threshold to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine." Clin Pharmacol Ther 49 (1991): 686-93. [PMID: 2249379]
318	Sindrup SH, Hofmann U, Asmussen J, Mikus G, Brosen K, Nielsen F, Ingwersen SH, Broen Christensen C "Impact of quinidine on plasma and cerebrospinal fluid concentrations of codeine and morphine after codeine intake." Eur J Clin Pharmacol 49 (1996): 503-9. [PMID: 8706777]
319	Thorn CF, Klein TE, Altman RB "Codeine and morphine pathway." Pharmacogenet Genomics 19 (2009): 556-8. [PMID: 19512957]
320	Vevelstad M, Pettersen S, Tallaksen C, Brors O "O-demethylation of codeine to morphine inhibited by low-dose levomepromazine." Eur J Clin Pharmacol 65 (2009): 795-801. [PMID: 19308365]
321	Zhou SF "Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II." Clin Pharmacokinet 48 (2009): 761-804. [PMID: 19902987]
322	Product Information. Enablex (darifenacin). Novartis Pharmaceuticals, East Hanover, NJ.
323	Multum Information Services, Inc. Expert Review Panel.
324	Product Information. Cerubidine (daunorubicin). Wyeth-Ayerst Laboratories, Philadelphia, PA.
325	Product Information. Daunoxome (daunorubicin liposomal). Nexstar Pharmaceuticals Inc, Boulder, CO.
326	Product Information. Idamycin (idarubicin). Pharmacia and Upjohn, Kalamazoo, MI.
327	Funck-Brentano C, Jacqz-Aigrain E, Leenhardt A, Roux A, Poirier JM, Jaillon P "Influence of amiodarone on genetically determined drug metabolism in humans." Clin Pharmacol Ther 50 (1991): 259-66. [PMID: 1914360]
328	Product Information. Fycompa (perampanel). Eisai Inc, Teaneck, NJ.
329	Warrington SJ, Ankier SI, Turner P "Evaluation of possible interactions between ethanol and trazodone or amitriptyline." Neuropsychobiology 15 (1986): 31-7. [PMID: 3725002]
330	Product Information. Arthrotec (diclofenac-misoprostol). Searle, Skokie, IL.
331	Ausband SC, Goodman PE "An unusual case of clarithromycin associated ergotism." J Emerg Med 4 (2001): 411-3. [PMID: 11728770]
332	Baldwin ZK, Ceraldi CC "Ergotism associated with HIV antiviral protease inhibitor therapy." J Vasc Surg 37 (2003): 676-8. [PMID: 12618710]
333	Bird PA, Sturgess AD "Clinical ergotism with severe bilateral upper limb ischaemia precipitated by an erythromycin - ergotamine drug interaction." Aust N Z J Med 30 (2000): 635-6. [PMID: 11108077]
334	Blanche P, Rigolet A, Gombert B, Ginsburg C, Salmon D, Sicard D "Ergotism related to a single dose of ergotamine tartrate in an AIDS patient treated with ritonavir." Postgrad Med J 75 (1999): 546-7. [PMID: 10616689]
335	Caballero-Granado FJ, Viciana P, Cordero E, Gomez-Vera MJ, del Nozal M, Lopez-Cortes LF "Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patient." Antimicrob Agents Chemother 41 (1997): 1207. [PMID: 9145904]
336	Dresser GK, Spence JD, Bailey DG "Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition." Clin Pharmacokinet 38 (2000): 41-57. [PMID: 10668858]
337	Eadie MJ "Clinically significant drug interactions with agents specific for migraine attacks." Cns Drugs 15 (2001): 105-18. [PMID: 11460889]
338	Francis H, Tyndall A, Webb J "Severe vascular spasm due to erythromycin-ergotamine interaction." Clin Rheumatol 3 (1984): 243-6. [PMID: 6236021]
339	Hayton AC "Precipitation of acute ergotism by triacetyloleandomycin." N Z Med J 69 (1969): 42. [PMID: 5304704]
340	Horowitz RS, Dart RC, Gomez HF "Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction." Arch Intern Med 156 (1996): 456-8. [PMID: 8607732]
341	Leroy F, Asseman P, Pruvost P, Adnet P, Lacroix D, Thery C "Dihydroergotamine-erythromycin-induced ergotism." Ann Intern Med 109 (1988): 249. [PMID: 3389610]
342	Liaudet L "Severe ergotism associated with interaction between ritonavir and ergotamine." BMJ 318 (1999): 771. [PMID: 10082701]
343	Liaudet L, Buclin T, Jaccard C, Eckert P "Severe ergotism associated with interaction between ritonavir and ergotamine." Br Med J 318 (1999): 771. [PMID: 10082701]
344	Matthews NT, Havill JH "Ergotism with therapeutic doses of ergotamine tartrate." N Z Med J 89 (1979): 476-7. [PMID: 314074]
345	Montero A, Giovannoni AG, Tvrde PL "Leg ischemia in a patient receiving ritonavir and ergotamine." Ann Intern Med 130 (1999): 329. [PMID: 10068398]
346	Mortier E, Pouchet J, Vinceneux P, Lalande M "Ergotism related to interaction between nelfinavir and ergotamine." Am J Med 110 (2001): 594. [PMID: 11347624]
347	Product Information. Cafergot (caffeine-ergotamine). Novartis Pharmaceuticals, East Hanover, NJ.
348	Product Information. D.H.E. 45 (dihydroergotamine). Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
349	Product Information. Migranal (dihydroergotamine nasal). Novartis Pharmaceuticals, East Hanover, NJ.
350	Rosenthal E, Sala F, Chichmanian RM, Batt M, Cassuto JP "Ergotism related to concurrent administration of ergotamine tartrate and indinavir." JAMA 281 (1999): 987. [PMID: 10086430]
351	Spiegel M, Schmidauer C, Kampfl A, Sarcletti M, Poewe W "Cerebral ergotism under treatment with ergotamine and ritonavir." Neurology 57 (2001): 743-4. [PMID: 11524501]
352	Srisuma S, Lavonas EJ, Wananukul W "Ergotism and factitious hypotension associated with interaction of ergotamine with CYP3A4 inhibitors." Clin Toxicol (Phila) (2014): 1-4. [PMID: 24978905]
353	Tribble MA, Gregg CR, Margolis DM, Amirkhan R, Smith JW "Fatal ergotism induced by an HIV protease inhibitor." Headache 42 (2002): 694-5. [PMID: 12482227]
354	Vila A, Mykietiuk A, Bonvehi P, Temporiti E, Uruena A, Herrera F "Clinical ergotism induced by ritonavir." Scand J Infect Dis 33 (2001): 788-9. [PMID: 11728055]
355	Ghali R, De Lean J, Douville Y, Noel HP, Labbe R "Erythromycin-associated ergotamine intoxication: arteriographic and electrophysiologic analysis of a rare cause of severe ischemia of the lower extremities and associated ischemic neuropathy." Ann Vasc Surg 7 (1993): 291-6. [PMID: 8391300]
356	Product Information. Cymbalta (duloxetine). Lilly, Eli and Company, Indianapolis, IN.
357	Skinner MH, Kuan HY, Pan A, et al. "Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers." Clin Pharmacol Ther 73 (2003): 170-7. [PMID: 12621382]
358	Elsharkawy AM, Schwab U, McCarron B, et al. "Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser." J Clin Virol 58 (2013): 331-3. [PMID: 23763943]
359	Product Information. Sustiva (efavirenz). DuPont Pharmaceuticals, Wilmington, DE.
360	Product Information. Afinitor (everolimus). Novartis Pharmaceuticals, East Hanover, NJ.
361	Product Information. Pepcid (famotidine). Merck & Co, Inc, West Point, PA.
362	Kantola T, Backman JT, Niemi M, Kivisto KT, Neuvonen PJ "Effect of fluconazole on plasma fluvastatin and pravastatin concentrations." Eur J Clin Pharmacol 56 (2000): 225-9. [PMID: 10952477]
363	Product Information. Lescol (fluvastatin). Novartis Pharmaceuticals, East Hanover, NJ.
364	Product Information. Intuniv (guanfacine). Shire US Inc, Florence, KY.
365	Corona G, Vaccher E, Sandron S, et al. "Lopinavir-ritonavir dramatically affects the pharmacokinetics of irinotecan in HIV patients with Kaposi's sarcoma." Clin Pharmacol Ther 83 (2008): 601-6. [PMID: 17713471]
366	Phansalker S, Desai AA, Bell D, et al "High-priority drug-drug interactions for use in electronic health records." J Am Med Inform Assoc 19 (2012): 735-43. [PMID: 22539083]
367	Product Information. Camptosar (irinotecan). Pharmacia and Upjohn, Kalamazoo, MI.
368	Product Information. Onivyde (irinotecan liposomal). Merrimack Pharmaceuticals, Cambridge, MA.
369	Product Information. Methotrexate (methotrexate). Lederle Laboratories, Wayne, NJ.
370	Karonen T, Filppula A, Laitila J, Niemi M, Neuvonen PJ, Backman JT "Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast." Clin Pharmacol Ther (2010):. [PMID: 20592724]
371	Product Information. Singulair (montelukast). Merck & Co, Inc, West Point, PA.
372	Product Information. ReVia (naltrexone). DuPont Pharmaceuticals, Wilmington, DE.
373	Product Information. Viramune (nevirapine). Boehringer-Ingelheim, Ridgefield, CT.
374	Product Information. Viramune XR (nevirapine). Boehringer Ingelheim, Ridgefield, CT.
375	Product Information. Zyprexa (olanzapine). Lilly, Eli and Company, Indianapolis, IN.
376	Bergmann TK, Filppula AM, Launiainen T, Nielsen F, Backman J, Brosen K "Neurotoxicity and low paclitaxel clearance associated with concomitant clopidogrel therapy in a 60 year old Caucasian woman with ovarian carcinoma." Br J Clin Pharmacol (2015):. [PMID: 26446447]
377	Bun SS, Ciccolini J, Bun H, Aubert C, Catalin J "Drug interactions of paclitaxel metabolism in human liver microsomes." J Chemother 15 (2003): 266-74. [PMID: 12868554]
378	Jamis-Dow CA, Klecker RW, Katki AG, Collins JM "Metabolism of Taxol by human liver microsomes and effect of inhibitors (Meeting abstract)." Proc Annu Meet Am Assoc Cancer Res 34 (1993): a21981993.
379	Product Information. Abraxane (paclitaxel protein-bound). American Pharmaceutical Partners, Schaumberg, IL.
380	Product Information. Taxol (paclitaxel). Bristol-Myers Squibb, Princeton, NJ.
381	Spencer CM, Faulds D "Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer." Drugs 48 (1994): 794-847. [PMID: 7530632]
382	Starr SP, Hammann F, Gotta V, et al. "Pharmacokinetic interaction between taxanes and amiodarone leading to severe toxicity." Br J Clin Pharmacol 450 (2016): 22-27. [PMID: 27868228]
383	Product Information. Definity (perflutren). Lantheus Medical Imaging Inc, North Billerica, MA.
384	Product Information. Optison (perflutren). Mallinckrodt Medical Inc, St. Louis, MO.
385	Aquilante CL, Kosmiski LA, Bourne DW, et al. "Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone." Br J Clin Pharmacol 75 (2013): 217-26. [PMID: 22625877]
386	Daily EB, Aquilante CL "Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies." Pharmacogenomics 10 (2009): 1489-510. [PMID: 19761371]
387	Deng LJ, Wang F, Li HD "Effect of gemfibrozil on the pharmacokinetics of pioglitazone." Eur J Clin Pharmacol 61 (2005): 831-6. [PMID: 16283275]
388	Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ "Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone." Clin Pharmacol Ther 77 (2005): 404-14. [PMID: 15900286]
389	Jaakkola T, Laitila J, Neuvonen PJ, Backman JT "Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro: potential for interactions with CYP2C8 inhibitors." Basic Clin Pharmacol Toxicol 99 (2006): 44-51. [PMID: 16867170]
390	Product Information. Actos (pioglitazone) Takeda Pharmaceuticals America, Lincolnshire, IL.
391	Scheen AJ "Pharmacokinetic interactions with thiazolidinediones." Clin Pharmacokinet 46 (2007): 1-12. [PMID: 17201456]
392	Totah RA, Rettie AE "Cytochrome P450 2C8: substrates, inhibitors, pharmacogenetics, and clinical relevance." Clin Pharmacol Ther 77 (2005): 341-52. [PMID: 15900280]
393	Wen X, Wang JS, Backman JT, Laitila J, Neuvonen PJ "Trimethoprim and sulfamethoxazole are selective inhibitors of CYP2C8 and CYP2C9, respectively." Drug Metab Dispos 30 (2002): 631-635. [PMID: 12019187]
394	Product Information. Esbriet (pirfenidone). Intermune Inc, Brisbane, CA.
395	Hanci V, Aydin M, Yurtlu BS, et.al "Anesthesia induction with sevoflurane and propofol: evaluation of P-wave dispersion, QT and corrected QT intervals." Kaohsiung J Med Sci 26 (2010): 470-7. [PMID: 20837343]
396	Kim DH, Kweon TD, Nam SB, Han DW, Cho WY, Lee JS "Effects of target concentration infusion of propofol and tracheal intubation on QTc interval." Anaesthesia 63 (2008): 1061-4. [PMID: 18717665]
397	Kleinsasser A, Kuenszberg E, Loeckinger A, et.al "Sevoflurane, but not propofol, significantly prolongs the Q-T interval." Anesth Analg 90 (2000): 25-7. [PMID: 10624970]
398	Kleinsasser A, Loeckinger A, Lindner KH, Keller C, Boehler M, Puehringer F "Reversing sevoflurane-associated Q-Tc prolongation by changing to propofol." Anaesthesia 56 (2001): 248-50. [PMID: 11251432]
399	Paventi S, Santevecchi A, Ranieri R "Effects of sevoflurane versus propofol on QT interval." Minerva Anestesiol 67 (2001): 637-40. [PMID: 11731753]
400	Scalese MJ, Herring HR, Rathburn RC, Skrepnek GH, Ripley TL "Propofol-associated QTc prolongation." Ther Adv Drug Saf 7 (2016): 68-78. [PMID: 27298717]
401	Staikou C, Stamelos M, Stavroulakis E "Impact of anaesthetic drugs and adjuvants on ECG markers of torsadogenicity." Br J Anaesth 112 (2014): 217-30. [PMID: 24305646]
402	Toyoda T, Terao Y, Oji M, Okada M, Fukusaki M, Sumikawa K "The interaction of antiemetic dose of droperidol with propofol on QT interval during anesthetic induction." J Anesth 27 (2013): 885-9. [PMID: 23660990]
403	Whyte SD, Booker PD, Buckley DG "The Effects of Propofol and Sevoflurane on the QT Interval and Transmural Dispersion of Repolarization in Children." Anesth Analg 100 (2005): 71-77. [PMID: 15616054]
404	Wutzler A, De Asmundis C, Matsuda H, et.al "Effects of propofol on ventricular repolarization and incidence of malignant arrhythmias in adults." J Electrocardiol 51 (2018): 170-4. [PMID: 29174097]
405	Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT "CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide." Br J Clin Pharmacol 56 (2003): 305-14. [PMID: 12919179]
406	Hatorp V "Clinical pharmacokinetics and pharmacodynamics of repaglinide." Clin Pharmacokinet 41 (2002): 471-83. [PMID: 12083976]
407	Niemi M, Kajosaari LI, Neuvonen M, Backman JT, Neuvonen PJ "The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects." Br J Clin Pharmacol 57 (2004): 441-7. [PMID: 15025742]
408	Skerjanec A, Wang J, Maren K, Rojkjaer L "Investigation of the pharmacokinetic interactions of deferasirox, a once-daily oral iron chelator, with midazolam, rifampin, and repaglinide in healthy volunteers." J Clin Pharmacol 50 (2010): 205-13. [PMID: 19940232]
409	Baldwin SJ, Clarke SE, Chenery RJ "Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone." Br J Clin Pharmacol 48 (1999): 424-32. [PMID: 10510156]
410	Hruska MW, Amico JA, Langaee TY, Ferrell RE, Fitzgerald SM, Frye RF "The effect of trimethoprim on CYP2C8 mediated rosiglitazone metabolism in human liver microsomes and healthy subjects." Br J Clin Pharmacol 59 (2005): 70-9. [PMID: 15606443]
411	Niemi M, Backman JT, Granfors M, Laitila J, Neuvonen M, Neuvonen PJ "Gemfibrozil considerably increases the plasma concentrations of rosiglitazone." Diabetologia 46 (2003): 1319-23. [PMID: 12898007]
412	Niemi M, Backman JT, Neuvonen PJ "Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone." Clin Pharmacol Ther 76 (2004): 239-49. [PMID: 15371985]
413	Product Information. Avandia (rosiglitazone) SmithKline Beecham, Philadelphia, PA.
414	Franco-Salinas G, de la Rosette JJ, Michel MC "Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations." Clin Pharmacokinet 49 (2010): 177-88. [PMID: 20170206]
415	Kamimura H, Oishi S, Matsushima H, et al. "Identification of cytochrome P450 isozymes involved in metabolism of the alpha1-adrenoceptor blocker tamsulosin in human liver microsomes." Xenobiotica 28 (1998): 909-22. [PMID: 9849639]
416	Product Information. Flomax (tamsulosin). Boehringer-Ingelheim, Ridgefield, CT.
417	Product Information. Thalomid (thalidomide). Celgene Corporation, Warren, NJ.
418	Edeki TI, He HB, Wood AJJ "Pharmacogenetic explanation for excessive beta-blockade following timolol eye drops: potential for oral-ophthalmic drug interaction." JAMA 274 (1995): 1611-3. [PMID: 7474246]
419	Fraunfelder FT, Fraunfelder FW Randall JA "Drug-Induced Ocular Side Effects 5th" Boston, MA: Butterworth-Heinemann (2001):.
420	Lewis RV, Lennard MS, Jackson PR, Tucker GT, Ramsay LE, Woods HF "Timolol and atenolol: relationships between oxidation phenotype, pharmacokinetics and pharmacodynamics." Br J Clin Pharmacol 19 (1985): 329-33. [PMID: 2859048]
421	Product Information. Aubagio (teriflunomide). Genzyme Corporation, Cambridge, MA.
422	Product Information. Tabloid (thioguanine). Prasco Laboratories, Cincinnati, OH.
423	Miners JO, Rees DLP, Valente L, Veronese ME, Birkett DJ "Human hepatic cytochrome p450 2c9 catalyzes the rate-limiting pathway of torsemide metabolism." J Pharmacol Exp Ther 272 (1995): 1076-81. [PMID: 7891318]
424	Product Information. Demedex (torsemide). Boehringer Mannheim, Gaithersburg, MD.
425	Vormfelde SV, Engelhardt S, Zirk A, et al. "CYP2C9 polymorphisms and the interindividual variability in pharmacokinetics and pharmacodynamics of the loop diuretic drug torsemide." Clin Pharmacol Ther 76 (2004): 557-66. [PMID: 15592327]
426	Product Information. Yondelis (trabectedin). Janssen Pharmaceuticals, Titusville, NJ.
427	Cerner Multum, Inc. "Canadian Product Information.".
428	Product Information. Ultram (tramadol). McNeil Pharmaceutical, Raritan, NJ.
429	European Medicines Agency Pharmacovigilance Risk Assessment Committee "PRAC recommendations on signals. Adopted at the PRAC meeting of 8-11 September 2014".
430	Product Information. Remodulin (treprostinil). United Therapeutics Corp, Silver Spring, MD.
431	Product Information. Nubeqa (darolutamide). Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ.
432	Product Information. Pifeltro (doravirine). Merck & Company Inc, Whitehouse Station, NJ.
433	Product Information. Movantik (naloxegol). Astra-Zeneca Pharmaceuticals, Wilmington, DE.
434	Product Information. Briviact (brivaracetam). UCB Pharma Inc, Smyrna, GA.
435	Product Information. Aricept (donepezil). Pfizer US Pharmaceuticals, New York, NY.
436	Rojas-Fernandez C, Fisher C "Drug interactions and donepezil." J Am Geriat Soc 40 (2000): 597-8. [PMID: 10811561]
437	Tiseo PJ, Perdomo CA, Friedhoff LT "Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses." Br J Clin Pharmacol 46 (1998): 30-4. [PMID: 9839763]
438	Kounas SP, Letsas KP, Sideris A, Efraimidis M, Kardaras F "QT interval prolongation and torsades de pointes due to a coadministration of metronidazole and amiodarone." Pacing Clin Electrophysiol 28 (2005): 472-3. [PMID: 15869686]
439	Product Information. Flagyl (metronidazole). Searle, Skokie, IL.
440	Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN). Aptalis Pharma, Birmingham, AL.
441	Crouch MA, Limon L, Cassano AT "Clinical relevance and management of drug-related QT interval prolongation." Pharmacotherapy 23 (2003): 881-908. [PMID: 12885102]
442	Darpo B "Spectrum of drugs prolonging QT interval and the incidence of torsades de pointes." Eur Heart J Suppl 3(Suppl K) (2001): K70-80.
443	Lopez JA, Harold JG, Rosenthal MC, Oseran DS, Schapira JN, Peter T "QT prolongation and torsades de pointes after administration of trimethoprin-sulfamethoxazole." Am J Cardiol 59 (1987): 376-7. [PMID: 3492908]
444	Wiener I, Rubin D, Martinez E, et al "QT prolongation and paroxysmal ventricular tachycardia occurring during fever following trimethoprim-sulfamethoxazole administration." Mt Sinai J Med 48 (1981): 53-5. [PMID: 6970886]
445	Brynne N, Svanstrom C, AbergWistedt A, Hallen B, Bertilsson L "Fluoxetine inhibits the metabolism of tolterodin-pharmacokinetic implications and proposed clinical relevance." Br J Clin Pharmacol 48 (1999): 553-63. [PMID: 10583026]
446	Product Information. Detrol (tolterodine). Pharmacia and Upjohn, Kalamazoo, MI.

Details of Drug

Details of Drug

Cite MecDDI

About MecDDI

Correspondence